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Preamble  
 
The Thesis “Structural Analysis of Induced Mutagenesis A’ Protein from Mycobacterium   
tuberculosis and of a Thermophillic GH9 Cellulase” consists of two parts, I and II that share one 
abstract. 
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Abstract 
The three-dimensional structures of proteins are important in understanding their function and 
interaction with ligands and other proteins. In this work, the structures of two proteins, ImuA’ 
from Mycobacterium tuberculosis and GH9 C1 cellulase from a metagenomic library, were 
analysed using structural biological and modelling techniques. The gene encoding ImuA’ was 
amplified by two-step PCR, cloned, and expressed in E. coli. The recombinant ImuA’ produced 
was found to be largely insoluble. The insoluble protein was successfully solubilized in 8 M urea 
but refolding the protein to its native structure was unsuccessful. By homology modelling, a 3D 
model of ImuA’ was obtained from a partly homologous protein RecA. In comparison to RecA, 
ImuA’ appears to lack some loop amino acids critical for DNA binding. Hence ImuA’ is postulated 
to not bind DNA. The second protein, GH9 C1 cellulase, was produced in E. coli. The protein was 
purified by chromatographic techniques and crystallized in a precipitant to protein ratio of 1:2 by 
hanging and sitting drop crystallization methods. The reservoir solution was made up of 15-30% 
(w/v) PEG 3350, 200 mM salt and 100 mM Tris-HCl pH 7.5-8.5. The protein crystals only diffracted 
X-rays to 4 Å resolution which could not be used to obtain a crystal structure of the protein. The 
diffraction data, however, showed the crystal to be monoclinic with space group P2. Homology 
modelling revealed GH9 C1 cellulase to be a two domain protein with a smaller N-terminal Ig-like 
domain and a larger catalytic domain. The catalytic domain retains two Ca2+ binding sites, which 
potentially stabilize the active site conformation and increase thermostability of the protein. 
Overall GH9 C1 cellulase is structurally similar to other GH9 cellulases, suggesting that its catalytic 
mechanism may be conserved.  
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1. Introduction 
 History and Epidemiology of Tuberculosis 
Tuberculosis (TB) is an communicable disease ranked with the human immunodeficiency 
virus/acquired immunodeficiency syndrome (HIV/AIDS) and malaria as amongst the most lethal 
infectious diseases (Dye et al., 1999). Tuberculosis claims over 2 million lives annually, primarily 
in developing countries. The disease has infected the human population throughout recorded 
human history. Modern evidence traces its existence back to the Pleistocene period, around 
17 000 years ago and has been documented for the pre-dynastic and early dynastic periods in 
Egyptian civilization (Bedeir, 2004; Donoghue et al., 2004). Evidence of TB has been confirmed in 
Egyptian mummies and human remains in India and China dating back to 3000 BC (Barnes, 2000; 
Daniel, 2006; El-Najjar et al., 1996). Tuberculosis was described as “consumptive disease” or 
“consumption” (for consuming a patient’s body), “white plague” (causes pale white skin) and 
“phthisis pulmonary” (for wasting away a patient’s body). In 1865, TB was shown to be 
contagious by transmitting it to animals. About two decades later, Robert Koch isolated the 
bacillus Mycobacterium tuberculosis (Mtb) as the etiological agent of TB (Rosenthal & Fisher, 
2013).  
Mtb is a non-motile, acid-fast, rod-shaped bacillus with a Gram positive mycolic acid cell wall. In 
humans the bacterium typically attacks the lungs causing pulmonary TB. It can, however, also 
infect other body parts, known as extra-pulmonary TB (Bordbar et al., 2010; Deb et al., 2009). In 
its host, the bacterium may either be cleared by the host immune system, remain in a latent 
state, or multiply into active disease (Primm et al., 2000). An estimated one-third of the world’s 
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population harbours latent Mtb and approximately 8-10 million new cases of active TB are 
recorded annually (McDonough et al., 1993; WHO, 2003). Co-infection with HIV/AIDS, the 
emergence of multi-drug resistant (MDR) and extensive drug resistant (XDR) strains of Mtb 
contribute to the global difficulties in the control of TB (Barry & Blanchard, 2010; Sacchettini et 
al., 2008).  
 Tuberculosis Treatment  
Drug susceptible TB is treatable with a combination of four first line drugs: isoniazid, rifampicin, 
ethambutol and pyrazinamide (Sharma & Mohan, 2013). This treatment achieved a success rate 
of over 85 % until the emergence of MDR-TB strains. Multi-drug resistant TB refers to resistance 
towards isoniazid and rifampicin, the most effective of the first line anti-TB drugs (WHO, 2012). 
The primary causes of MDR-TB include poor patient management, non-compliance to prescribed 
regimen, poor national awareness programs or a combination of the three (Davies, 2001). Multi-
drug resistant TB is, however, still treatable with a combination of first and second line drugs. 
Second line TB drugs include cycloserine, fluoroquinones (ciprofloxacin and ofloxacin) and 
aminoglycoside injectables (kanamycin, amikacin or capreomycin). The main disadvantage of 
second line drugs is that they have more side effects than their first line counterparts (Kapoor et 
al., 2013) and are difficult to administer. Treatment of MDR-TB extends for over 18 months with 
a daily dose of various medications (Iseman, 1993). This extended treatment period often results 
in patient non-compliance to treatment regimens, potentially the cause for extensive drug 
resistant TB. XDR-TB is defined as resistance to both isoniazid and rifampicin plus one 
fluroquinolone and any of the second line injectables (Ehrt & Schnappinger, 2009).  
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 Management of Tuberculosis  
In 1995, the World Health Organization (WHO) introduced the Directly Observed Therapy - Short 
Course (DOTS). DOTS is a patient-centred health care management system with five key pillars: 
i) the detection of smear-positive pulmonary TB by sputum microscopy; ii) treatment with short-
course chemotherapy during which the patient is directly-observed by a healthcare worker or 
family member in taking their TB treatment; iii) continuous drug supply; iv) government 
commitment to ensure TB control activities; and v) documentation of patient treatment 
outcomes (Obermeyer et al., 2008; Obiri-Danso et al., 2013; Volmink & Garner, 2007). The DOTS 
strategy recommends an intensive treatment with first-line drugs for a minimum period of six 
months. In this treatment, all four first line drugs are administered for two months, followed by 
four months of continuous treatment with isoniazid and rifampicin (Hall et al., 2009; WHO, 2009). 
The DOTS TB management strategy has been implemented in most TB endemic countries, 
including China and India. Since its implementation, TB incidence worldwide has declined from 
2000 onward (Zumla et al., 2013). However, attributing the decline in TB incidences to DOTS 
alone is controversial as TB has also declined in areas without DOTS implementation. Further, 
direct supervision of patients leads to stigmatization and reduced acceptance in areas with high 
TB-HIV/AIDS co-infection and in MDR-TB affected areas (Out et al., 2014; Volmink & Garner, 
2007).  
 Immunology of Tuberculosis Infection 
Mtb most commonly infects its host through aerosolized droplets, coughed up by actively 
shedding carriers of the bacillus (Rothman et al., 2006). The droplets are inhaled by individuals 
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in the immediate vicinity and reach the lungs, the site of infection. Here, the bacterium infects 
individual endothelial cells, but more importantly encounters alveolar macrophages and 
dendritic cells - the first line of defence within the lungs (Raja, 2004). Alveolar macrophages 
engulf the bacilli and attempt to destroy them using an array of antimicrobial pathways. 
Additionally, alveolar macrophages and dendritic cells process the bacteria for presentation of 
peptides to naïve T-cells. The dendritic cells then transport the bacteria and their antigens to the 
draining lymph nodes to activate CD4+ and CD8+ T-cells (Silva & Lowrie, 2000). The T-cells migrate 
back to the lungs to activate more alveolar macrophages, stop the bacterial replication and 
remove the invader. While the host is thus initially able to control the spread of Mtb, about 5% 
of bacilli escape clearance and remain latent within the host (Ahmad, 2011). In 5 to 10% of 
latently infected individuals, bacilli will reactivate into active disease especially if the immune 
system is compromised (Flynn & Chan, 2001; Kaufmann & McMichael, 2005; Wolf et al., 2007). 
The inability of the host to clear the infection completely has made Mtb such a successful 
pathogen (Chan et al., 1991; Flynn & Chan, 2001). 
 Mycobacterium tuberculosis DNA Damage  
The host immune response exposes Mtb to a range of DNA-damaging agents such as reactive 
oxygen and nitrogen intermediates (Stewart et al., 2003). These chemical species can react and 
corrupt Mtb DNA. Mycobacterium tuberculosis survival is thus critically dependent on its ability 
to repair affected DNA (Mizrahi & Andersen, 1998). DNA damage leads to up-regulation of genes 
that encode DNA polymerases involved in DNA repair. One such  polymerase, DnaE2, is a member 
of the C-family of DNA polymerases (Boshoff et al., 2003). DnaE2-dependent DNA repair is linked 
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to a high rate of induced mutagenesis (Koorits et al., 2007) mediated in bacteria such as E. coli 
by Y-family polymerases, members of which are also known for Mtb (Jarosz et al., 2007; Kana et 
al., 2010). 
 DNA Replication  
1.6.1 Eukaryotic and Prokaryotic DNA Polymerases  
To accurately copy both strands of DNA is the responsibility of DNA polymerases and accessory 
proteins, together constituting so-called replicases. Universally, replicases have three 
components: a polymerase (Pol III in prokaryotes, Pols δ and ε in eukaryotes), a sliding clamp 
processivity factor and a clamp loader. Without accessory proteins, replicative polymerases are 
largely indistinguishable from other cellular polymerases. With their accessory proteins, they 
become highly specialized (Fay et al., 1981; Kornberg & Baker, 1992). 
DNA replication commences with the ATP-dependent formation of an initiation complex by a 
DNA polymerase holoenzyme (Wickner & Kornberg, 1973). The clamp loader guides the 
polymerase to a sliding clamp where it proceeds to add bases to the DNA strand (Downey & 
McHenry, 2010). 
Though similar, eukaryotic and prokaryotic replicative polymerases do differ. Firstly, B- and C-
family DNA polymerases respectively replicate eukaryotic and prokaryotic DNA (Braithwaite & 
Ito, 1993). Secondly, eukaryotic clamp loaders rarely interact with polymerases whereas 
prokaryotic counterparts tightly interact with Pol III and helicases (Kim & McHenry, 1996). Low 
GC, Gram positive bacteria are intermediate with clamp loaders weakly interacting with Pol III 
but strongly with helicases (Rannou et al., 2013). Thirdly, eukaryotic DNA replication involves 
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three replicative polymerases: the leading and lagging strand polymerases Pol ε and Pol δ, and 
Pol α, which adds dNTPs to RNA primers at the start of Okazaki fragments on the lagging strand 
before handing over to Pol δ (Nick McElhinny et al., 2008). Gram negative prokaryotes, by 
contrast, have a single polymerase, the Pol III holoenzyme, whereas Gram positive bacteria have 
two Pol III enzymes. Some bacteria that lack the error-prone Pol V encode a third Pol III, which 
can induce mutagenesis (Afonso et al., 2013; Bruck et al., 2005; Gao & McHenry, 2001; Haroniti 
et al., 2004). 
1.6.2 Prokaryotic Pol III Enzymes 
Low GC Gram positive bacteria have two Pol III enzymes, the homologues Pol C and DnaE differing 
by some domain rearrangements (Koonin, & Bork, 1996; Rannou et al., 2013). Pol C has a Mg2+-
dependent proof reading ability absent in DnaE. DnaE is more closely related to the lone E. coli 
Pol III holoenzyme (Afonso et al., 2013) but functionally mimics eukaryotic Pol α (Sanders et al., 
2010) in using RNA primers to extend the lagging strand before handing over to Pol C (McHenry, 
2011a; Sanders et al., 2010). A third Pol III enzyme, DnaE2 or ImuC, is found in diverse bacterial 
phyla and is responsible for translesion synthesis. This polymerase is produced alongside ImuA 
and ImuB in response to DNA damage via the SOS response mechanism. 
1.6.3 The SOS Response Mechanism 
The “Save Our Souls” (SOS) response mechanism is a bacterial DNA repair system first described 
in E. coli in 1974 (Erill et al., 2007; Patel et al., 2010; Witkin, 1967). It up-regulates production of 
Y-family polymerases that synergize with bacterial repair proteins to repair damaged DNA. The 
SOS response has been implicated in bacterial integrase regulation and stress induced 
 
 
 
 
7 
 
mutagenesis as well as Mtb virulence and antibiotic resistance (Sanchez-Alberola et al., 2012; 
Žgur-Bertok, 2013). 
SOS response genes are regulated by the 27 kDa, dimeric transcriptional repressor LexA. LexA 
binds a palindromic “SOS box”, which mostly overlaps with RNA polymerase binding sites to 
prevent SOS regulon transcription and down-regulate SOS genes. At least 50 genes of this regulon 
have been identified (Galhardo et al., 2007; Kim et al., 1997; McKenzie et al., 2000; Qiu & 
Goodman, 1997). 
RecA, another critical protein, binds damage-induced, single-stranded DNA (ssDNA) to form a 
ssDNA/RecA nucleofilament denoted RecA* or “activated RecA”. This induces LexA auto-cleavage 
to release it from the SOS box (Lavery & Kowalczykowski, 1992). RNA polymerase then binds the 
free promoter and transcribes the SOS regulon. Products of this regulon repair damaged DNA, 
displacing and inactivating RecA*. LexA, itself SOS-regulated, accumulates to once more repress 
the regulon (Butala et al., 2008). 
Though highly conserved in bacteria, the SOS response differs with respect to the LexA 
recognition sequence and the set of genes under LexA control (da Rocha et al., 2008). The E. coli 
SOS box CTGTN8ACAG is found in most β and γ proteobacteria. Gram positive bacteria, non-
sulphur bacteria and cyanobacteria by contrast share a GAACN4GTTY SOS box. Other SOS boxes 
include GTTCN7GTTC in α proteobacteria and TTAN6TACTA in Xanthomonadales (Erill et al., 2006). 
Bacteria such as Geobacter sulfurreducens have two lexA genes whose gene products bind the 
same SOS box (Jara et al., 2003), whereas the two LexA proteins of Pseudomonas and 
Xanthomonas recognize unrelated SOS boxes. LexA1 of Pseudomonas putida in turn binds an 
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E. coli-like SOS box while its LexA2 shares an SOS box with LexA2 of Xanthomonas (Abella et al., 
2007). LexA2 is frequently co-transcribed with the common bacterial genes imuA, imuB and 
dnaE2 implicated in DNA damage induced mutagenesis (Aravind et al., 2007; Galhardo et al., 
2007; Sanchez-Alberola et al., 2012). This gene cassette has undergone various reorganizations 
with three genes, two genes and a complete split but invariably remains LexA regulated (Abella 
et al., 2007). 
SOS regulon genes are expressed neither at the same level nor at the same time. Instead, 
expression levels and initiation time depends on the type of lesion and its severity (Žgur-Bertok, 
2013). In case of severe DNA damage, the SOS gene product SfiA (or SulA) is produced (Burhans 
et al., 2003; Campoy et al., 2005), which participates in cell division arrest to allow for repair 
mechanisms to occur (Crowley & Courcelle, 2002; Janion et al., 2002).  
1.6.4 Y-family Polymerases  
Specialized Y-family polymerases are DNA polymerases induced by the bacterial SOS response 
(Walsh et al., 2011; Yang, 2003). Y-family polymerases are found in all domains of life and are of 
critical importance as they replicate DNA lesions in a damaged DNA tolerance process called 
translesion synthesis (Waters et al., 2009), something replicative polymerases are unable to do 
(Ippoliti, 2012). Y-family polymerases have low fidelity and induce mutations when replicating 
undamaged DNA (Rattray & Strathern, 2003). 
1.6.5 Y-family Polymerases Versus Replicative Polymerases 
Y-family polymerases share structural features distinct from replicative polymerases. All share 
palm, finger, thumb and little finger domains. However, the little finger and thumb domains are 
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smaller in Y-family polymerases allowing them to accommodate bulky DNA lesions in their active 
site (Chandani et al., 2010; Ling et al, 2001; Washington et al., 2010). Y-family polymerases 
further lack the intrinsic 3’-5’ exonuclease proofreading and the ‘O’-helix required for fidelity in 
replicative polymerases to accommodate damaged DNA (Patel et al., 2001; Waters et al., 2009). 
1.6.6 E. coli Y-family Polymerases and their Orthologues in Other Bacteria  
The two Y-family polymerase in E. coli with translesion synthesis activity, DNA Pol IV (DinB) and 
DNA Pol V (UmuD'2C), are regulated by UmuD (Beuning et al., 2006) and all three genes dinB, 
umuC and umuD are co-regulated (Opperman et al., 1996). Within 20 to 40 min after SOS 
induction, umuD primarily produces UmuD2, a UmuD dimer (Smith & Walker, 1998). UmuD2 
interacts with RecA and ssDNA nucleoprotein filaments prompting auto-cleavage dependent 
conversion of UmuD to UmuD’ by the removal of 24 N-terminal amino acids and the related 
conversion of Dimeric UmuD2 to UmuD2’. The latter combines with UmuC to form UmuD2’C (Pol 
V), a Y-family polymerase with translesion synthesis activity (Hare et al., 2006; Ippoliti et al., 
2012). UmuD2 prevents mutations by DinB and UmuC whereas UmuD2’ facilitates mutagenesis 
through UmuD2’C complex (Pol V). Cleavage of UmuD2 is therefore a switch from a non-
mutagenic to a mutagenic state in cells (Ippoliti et al., 2012; Ollivierre et al., 2010). 
In Mtb, the genes Rv1537 and Rv3056 encode two Y-family polymerases, DinB1 (DinX) and DinB2 
(DinP), both homologues of E. coli DinB. Surprisingly, their expression is independent of the SOS 
response (Cole et al., 1998; Kana et al., 2010; Rand et al., 2003). DinB1 is produced in pulmonary 
TB and DinB2 upon exposure to novobiocin (Boshoff et al., 2004). An unrelated protein DnaE2 
(ImuC), a C-family polymerase, is produced in response to Mtb DNA damage (Ippoliti et al., 2012).  
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1.6.7 The DnaE Proteins 
DNA polymerase III (Pol III) is the main replicative polymerase in bacteria. Pol III is a C-family 
enzyme complex with ten subunits (Rachman et al., 2006). Its α-subunit, DnaE or Pol C, is the 
replicative enzyme of the complex (Braithwaite & Ito, 1993; Ito & Braithwaite, 1991). Two or 
three forms of DnaE are encoded by E. coli from the same gene, dnaE, whereas B. subtillis 
encodes two forms of DnaE from two different genes, dnaE and pol C (Bruck et al., 2003; Le 
Chatelier et al., 2004).  
Mycoplasma and Mycobacterium species encode two genes related to E. coli dnaE referred to as 
dnaE1 or Rv1547c and dnaE2 or Rv3370c. DnaE2, however, lacks the conventional 3’-5’ 
exonuclease domain of C-family polymerases. DnaE2 proteins are generally not essential for 
replication but are required for damage-induced mutagenesis and translesion synthesis. They are 
typically complemented by either ImuA, ImuB or both (McHenry, 2011b). Note that this DnaE2 
nomenclature conflicts with that of cyanobacteria where DnaE1 and DnaE2 denote two parts of 
a functional Pol C subunit formed after the excision of an intein (Liu & Yang, 2003). It was 
therefore proposed that DnaE2 proteins involved in damage induced mutagenesis and 
translesion synthesis be renamed “ImuC” as a logical extension of DnaE2 accessory proteins ImuA 
and ImuB (Galhardo et al., 2007; Warner et al., 2010).  
1.6.8 The DnaE2 (ImuC) Accessory Proteins ImuA and ImuB  
Induced mutagenesis protein A (ImuA) of proteobacteria and the partly homologous ImuA’ of 
Mtb resemble E. coli and M. smegmatis LexA and RecA (Campoy et al., 2005; Erill et al., 2005). 
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Despite a sequence identity of 37%, ImuA’ cannot complement a recA- mutant strain (Campoy et 
al., 2005; Warner et al., 2010). The function of ImuA’ thus essentially remains unknown. 
Induced mutagenesis B protein (ImuB) and its Deinoccocus deserti homolog ImuY are both 
involved in translesion synthesis (Dulermo et al., 2009). Although homologous to Y-family 
polymerases, ImuB lacks critical active site aspartic acids rendering it catalytically inactive 
(Warner et al., 2010). DnaE2 (ImuC), by comparison, is catalytically active but lacks the β-clamp 
binding domain of ImuB. ImuB and ImuC thus complement each other to create a functional 
translesion synthesis polymerase (Warner et al., 2010). The genetic arrangement of the imuA, B 
and C cluster is quite diverse. Kineococcus radiotolerans, for example, has a lone imuC gene, 
Streptomyces coelicolor has an imuB-C combination, while Pseudomonas putida has a complete 
imuA-B-C cassette. In Mtb, imuA’-B form a cassette but imuC is in a different locus. In extreme 
cases, all three genes are in separate loci with distinct SOS boxes (Erill et al., 2007, 2006). 
Alternatively, the three genes may be spread over both strands of the chromosome or plasmids 
in either orientations (Abella et al., 2004, 2007). 
1.6.9 The Mtb imuA’, imuB, imuC Mutagenic Cassette  
Expression of Mtb imuC is up-regulated 10-fold following mitomycin C (MMC) treatment or UV 
irradiation. The imuC gene is preceded by a LexA SOS box and is co-regulated with recA, lexA, 
imuA’ and imuB. Deletion mutant strains of Mtb imuC (ΔimuC) lose UV-induced mutagenesis and 
are less virulent in mice (Boshoff et al., 2003; Davis et al., 2002). Conversely, elevated levels of 
ImuC are not mutagenic without UV exposure. ImuC thus requires partners to function (Boshoff 
et al., 2003). Furthermore, Mtb ΔimuA’, ΔimuB or ΔimuC mutant strains or any combination 
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thereof are hypersensitive to MMC and UV. This links ImuA’, ImuB and ImuC to a single UV/MMC 
resistance pathway in Mtb (Warner et al., 2010).  
ImuB binds both ImuA’ and ImuC, but ImuA’ and ImuC do not physically interact (Warner et al., 
2010). An ImuA’BC complex is therefore assumed to be essential for induced mutagenesis, Mtb 
virulence and DNA repair/survival after exposure to antibiotics or UV. Understanding these 
interactions at a structural level may allow the rational development of new Mtb drugs 
(Ndwandwe, 2013). As the determination of complex structure may be difficult and protracted, 
solving the structure of individual members could represent an alternative strategy. 
 Aim and Objectives 
The aim of this project is to determine the crystal structure of ImuA’ from Mtb. The objectives 
are to:  
1. Analyse the ImuA’ amino acid sequence using bioinformatics techniques.  
2. Design primers to amplify imuA’ by PCR and clone into protein production plasmids.  
3. Produce ImuA’ as a recombinant fusion protein with His6- and/or GST-tags. 
4. Purify the protein using chromatographic techniques. 
5. Crystallize the protein. 
6. Determine its crystal structure by X-ray crystallographic methods.  
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2. Materials and Methods 
 General Chemicals and Enzymes 
All the reagents used in this study were of analytical grade: 
Table 1: Reagents and Suppliers  
40% 37.5:1 Acrylamide:bis-acrylamide Bio-Rad 
Agarose  Lonza 
Ammonium persulphate (APS)  Merck 
Ampicillin  Roche 
Bacteriological agar  Merck 
Bromophenol blue  Sigma 
Coomasie brilliant blue R250  Sigma 
Dithiothreitol (DTT)  Roche 
DNase  Roche 
Ethylene diamine tetra acetic acid (EDTA)  Merck 
Ethanol  BDH 
Glacial acetic acid  Merck 
Glycine  BDH 
Hydrochloric acid (HCl)  Merck 
Isopropyl-D-1-thiogalactopyranoside (IPTG)  Roche 
Kanamycin monophosphate  Roche 
Lysozyme  Roche 
Potassium chloride  Merck 
Phenylmethylsulphonyl fluoride (PMSF)  Roche 
Protein molecular weight standard  Fermentas 
Reduced glutathione (GSH)  Sigma 
Restriction enzymes  Fermentas 
Sodium dodecyl sulphate (SDS)  Promega 
Sodium chloride  Merck 
Sodium hydroxide  Merck 
T4 Ligase  Fermentas 
TEMED (N, N, N`, N`- Tetra methylethylene-diamine)  Promega 
Tris (Tris[hydroxymethyl] aminoethane)  BDH 
Triton X-100 (Iso-octylphenoxypolyethoxyethanol)  Roche 
Tryptone  Merck 
Tween 20 (Polyoxyethylene [20] sorbitan)  Merck 
Yeast extract  Merck 
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 Stock Solutions, Buffers and Media 
Solutions were autoclaved at 120°C for 20 min unless otherwise indicated. 
Table 2: Stock solutions and their compositions 
Stocks Solutions Composition  
4 x Separating gel buffer 1.5 M Tris-HCl pH 8.8  
4 x Stacking gel buffer 0.5 M Tris-HCl pH 6.8 
5 x SDS running buffer 25 mM Tris pH 8.3, 0.1% SDS and 250 mM glycine,  
6 x DNA loading dye 0.25% (w/v) bromophenol blue, 0.25% (w/v) xylene 
cyanol FF and 30% (v/v) glycerol. 
10 x Phosphate-buffered saline (PBS) 80 g NaCl, 2 g KCl, 14.4 g Na2HPO4, 2.4 g KH2PO4, was 
dissolved by stirring in 800 mL deionized water. The pH 
of the solution was adjusted to 7.4 with HCl and filled to 
1 L with deionised water 
Ammonium persulphate 10% (w/v) stock solution was prepared in deionised 
water 
Ampicillin A 100 mg/mL stock solution was prepared in distilled 
water 
Cell lysis buffer 150 mM NaCl, 50 mM Tris-HCl pH 7.5, 5.0 mM DTT, 
200 g/mL lysozyme, 35 g/mL DNase, 1.0 mM PMSF, 
5 mM EDTA, 2% (w/v) Triton X-100, 1 EDTA-free 
Complete Protease Inhibitor Cocktail Tablet (Roche) 
Coomassie staining solution 0.25% (w/v) Coomassie Brilliant Blue R-250, 30% (v/v) 
ethanol, 10% (v/v) acetic acid  
Destaining solution 40% (v/v) ethanol, 10% (v/v) acetic acid  
DTT A 1 M stock solution was prepared in 0.01 M sodium 
acetate pH 5.2 and sterilised by filtration 
EDTA A stock solution of 0.5 M, pH 8.0 was prepared in 
distilled  water 
IPTG  A 1 M stock solution was prepared in distilled water and 
sterilised by filtration 
Luria bertani media (LB media) 10 g/L tryptone, 5 g/L yeast extract and 5 g/L NaCl. 
Solution was sterilised by autoclaving 
LB agar plates 31 g nutrient agar, 5 g NaCl, 5 g yeast extract, and 10 g 
tryptone were dissolved in 1 L of water and sterilised by 
autoclaving. The medium was allowed to cool and 
100 g/mL of ampicillin or kanamycin was added. The 
medium was poured into sterile plates in a laminar flow 
cabinet  
Lysozyme A 50 mg/mL of lysozyme solution was prepared in 
deionized water 
PreScission 3C protease cleavage buffer 50 mM Tris-HCl pH 7.0, 150 mM NaCl, 5 mM DTT, 
1.0 mM EDTA 
10X TAE 48.4 g Tris-base, 10.9 g glacial acetic acid, 2.92 g EDTA 
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 Plasmids and Bacterial Strains 
2.3.1 Plasmids and their Properties 
Table 3: Names, features and suppliers of plasmids used in this study  
Plasmid Size (bp) Selection Tag Cleavage site Supplier 
pGEX-6P-2 4 985 AmpR N-GST PreScission protease GE Healthcare 
 
pETM-30 
 
6 346 
 
KanR 
N-His,  
N-GST 
C-His 
 
TEV 
 
EMBL 
pCOLD I 4 407 AmpR N-His Factor Xa Takara Bio Inc. 
 
2.3.2 Bacterial Strains 
Table 4: Bacterial strains used in this study 
E. coli strain Function Supplier  
Artic Express Protein production at low temperature Agilent Technologies 
BL21 (DE3) Production of proteins  Stratagene 
BL21-CodonPlus Protein production and supplies rare codons Stratagene 
DH5α Plasmid DNA propagation Stratagene 
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 Naming of imuA’S and imuA’L 
The gene sequence for Mtb imuA’ (Rv3395c) was retrieved from three databases: TubercuList 
(tuberculist.epfl.ch/quicksearch.php?gene+name=rv3395c); the CMI JCVI  
(cmr.jcvi.org/cgibin/CMR/shared/GenePage.cgi?locus=NTL02MT03387) and the TB databases 
(genome.tbdb.org/annotation/genome/tbdb/GeneDetails.html?sp=S7000000635256581). 
The imuA’ sequence invariably consisted of 602 bp. However, the CMI JCVI database, provides a 
second open reading frame for imuA’ with an earlier start codon adding 270 bp to the 5’- end. In 
this study, the 602 bp sequence is denoted imuA’S (S for short) and the longer gene as imuA’L. 
Both sequences were cloned and expressed in E. coli. 
  Cloning  
2.5.1 Primers for Amplification of imuA’S and imuA’L by Polymerase Chain 
Reaction (PCR) 
PCR primers (table 5) were designed with the aid of DNAMAN sequence analysis software 
(Lynnon Corp., Canada) taking into account primer lengths, GC-content, restriction enzyme cut 
sites, 5’ and 3’ overhangs for restriction enzyme cut site recognition, self-complimentary ends, 
melting temperatures and in-frame cloning. 
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Table 5: Primers for Two-step Amplification of imuA’  
Restriction sites underlined, annealing sequence in bold.  
2.5.2 PCR Amplification of imuA’S and imuA’L  
2.5.2.1 Standard PCR Protocol 
A standard protocol for gene amplification (three-step PCR) was initially used to amplify imuA’ 
using the Roche FastStart Taq DNA Polymerase Kit. The reaction consisted of 200 ng template 
DNA (Mtb H37Rv genomic DNA), 1 x GC-RICH solution, 200 µM dNTP, 2 U Faststart Taq DNA 
polymerase (Roche Applied Science) and 10 pmol of forward and reverse primers, in a final 
volume of 50 µL. The amplification protocol was as follows: initial denaturation at 94°C for 5 min; 
30 cycles consisting of denaturation at 94°C for 60 s, annealing for 30 s at 60°C and extension at 
72°C for 60 s, a final extension at 72°C for 7 min. Amplified DNA fragments were analysed on a 
1% agarose gel. 
Name of primer Primer sequence (5’…3’) Tm (°C) GC % 
pETM-30_imuA’L Fd (NcoI) GACTCCATGGGCGTGCCGGTTAGTGCGATA 65 60 
pETM-30_imuA’S Fd (NcoI) CGACTCCATGGGCATGACTGCGGCCTT 58 63 
pETM-30_imuA’ Rv (XhoI) ACAGTCTCGAGCCGTCCACGCCCGTT 61 73 
pCOLD I_ imuA’L Fd (KpnI) AGACTGGTACCGTGCCGGTTAGTGCGATA 56 56 
pCOLD I_ imuA’L Rv (EcoRI) ACAGTGAATTCCCGTCCACGCCCGTT 61 73 
pGEX-6P-2_imuA’S Fd (HindIII)  AAGACTGGATCCATGACTGCGGCCTT 48 57 
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2.5.2.2  Gradient PCR  
Nine 0.5 mL PCR tubes with reaction mixture as outlined for standard PCR protocol (2.3.2.1) were 
used with annealing temperature varying between 52 and 68°C at 2°C interval.  
2.5.2.3  Two-step PCR  
Two-step PCR DNA amplification eliminates the annealing temperature step of standard PCR 
protocols (three-step PCR). Here, the Phusion High Fidelity DNA Polymerase Kit (Finnzymes), was 
used to amplify imuA’ by two-step PCR using Mtb (H37Rv) genomic DNA. Primers (Table 4) with 
3’-terminal adenine (A) or thymine (T) instead of the generally recommended guanine (G) or 
cytosine (C) were used to increased primers specificity in a GC-rich gene like imuA’. The reactions 
were set up to a final volume of 50 μL containing: 1 x Phusion GC buffer (Finnzymes), 200 ng 
genomic DNA, 200 μM dNTP, 0.5 μM each primer, 3% DMSO and 2 U of Phusion Hf DNA 
polymerase. DNA amplification was performed using the following cycling parameters: 
denaturation at 98°C for 30 s, followed by 25-35 cycles of denaturation at 98°C for 10 s and 
extension at 72°C for 30 s/kbp. A final extension at 72°C for 7 min. 
2.5.3 Agarose Gel Electrophoresis of DNA 
DNA sizes were analysed on 1% agarose gels stained with 1 x GRGreen nucleic acid stain (Biotium 
Inc.). Agarose gels were prepared by boiling 1 g agarose in 100 mL of 1 x TAE buffer (Table 2). The 
dissolved agarose solution was allowed to cool to 60°C whereupon 5 µL GRGreen dye was added 
and mixed by careful swirling to avoid foaming. The stained solution was poured into gel plates, 
combs inserted, and solution allowed to set for 15 to 30 min. DNA size marker (mostly GeneRuler 
1 kb DNA ladder, Thermo Scientific) was loaded alongside samples for size estimation. DNA 
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samples were stained with 1 x loading dye (Table 2) and loaded into wells on the agarose gel. 
Generally, gels were run at 100 V for 60 min, unless otherwise stated. 
2.5.4 Extraction and Purification of DNA from Agarose Gels 
PCR products or digested plasmid DNA in agarose gels were visualized using UV light. Essential 
DNA bands were manually excised from gel with a scalpel and transferred into clean Eppendorf 
tubes. DNA was purified using the GeneJet Gel Purification Kit (Thermo Scientific) according to 
manufacturer’s instructions. 
2.5.5 Restriction Enzyme Digestion of DNA  
Standard restriction enzyme protocols were used to digest DNA using FastDigest restriction 
enzymes (Thermo Scientific Fermentas). Generally, 1 to 2 µg of plasmid DNA or 0.2 to 0.5 µg of 
PCR products were digested with 0.1 U/µL each of the appropriate restriction enzyme in a final 
volume of 20 µL. The reactions were generally incubated at 37°C for 20 to 40 min. Digestion 
reactions were analysed on 1% agarose gels and fragments of interest were excised and purified 
using the GeneJet Gel Purification Kit (Thermo Scientific).  
2.5.6 Ligation of DNA Molecules  
Ligation reactions were carried out using a vector and an insert previously digested with 
restriction enzymes to produce matching sticky ends. Ligation reactions consisted of 50 to 100 ng 
of vector, 5 to 20 ng of insert DNA and 1 U of T4 DNA ligase (Thermos Scientific) in a final volume 
of 20 µL. Ligation reactions were allowed to proceed at room temperature for 3 h. 
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2.5.7 Quantification of DNA 
DNA concentrations and purities were determined using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, Inc.) by comparing absorbances at 260 nm and 
280 nm. A ratio of absorbance at 260 to 280 nm of ~1.8 was accepted as indicative of pure DNA. 
Appreciably lower ratios indicate contamination by proteins, phenols or other compounds 
absorbing at 280 nm, while higher ratios indicate contamination with RNA. 
2.5.8 Preparation of Chemically Competent E. coli Cells  
An appropriate strain of E. coli was plated on LB plates and incubated overnight at 37°C. A single 
colony from the plate was used to inoculate 5 mL of LB broth, which in turn was incubated for 
16 h at 37°C in a shaker incubator shaking at 170 rpm. The culture was used to inoculate 100 mL 
LB broth and further incubated until the OD600 was between 0.4 and 0.6. The culture was cooled 
on ice and centrifuged at 11 000 x g for 10 min at 4°C. The supernatant was discarded and the 
cell pellet resuspended in 35 mL ice-cold transformation buffer: 55 mM MnCl2, 15 mM CaCl2, 
250 mM KCl and 10 mM PIPES pH 6.7. The cell suspension was incubated on ice for 15 min and 
centrifuged at 11 000 x g and 4°C. The supernatant was discarded and the cell pellet gently 
resuspended in 2 mL ice-cold transformation buffer. The cell resuspension was centrifuged at 
4 500 x g at 4°C for 5 min using a bench top refrigerator centrifuge. The supernatant was 
discarded and cell pellet resuspended in 100 mM CaCl2 solution containing 20% glycerol. Equal 
volumes (50 µL) of the cells were aliquotted into 1.5 mL Eppendorf tubes, flash cooled in liquid 
nitrogen and stored at -80°C. 
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2.5.9  Antibiotic Selection 
In experiments with E. coli containing ampicillin or kanamycin resistant plasmids, transformed 
cells were plated on nutrient agar containing 100 µg/mL ampicillin or 25 µg/mL kanamycin. 
Selection was maintained during growth in liquid culture by adding appropriate antibiotics at the 
same concentration into the liquid culture. 
2.5.10 Bacterial Transformation 
Generally, 50 μl of competent E. coli cells were transformed with 25 to 50 ng of plasmid DNA. 
First, cells were thawed on ice and incubated with DNA for at least 30 min. Cells were then heat 
shocked at 42°C for 45 s and chilled on ice for 2 min. 800 µL of pre-warmed LB was added to the 
transformed cells and incubated with shaking at 37˚C for 1 h. One tenth of the cells were plated 
onto LB agar plates with appropriate antibiotics and incubated overnight. As a control, 
untransformed competent cells were plated on agar plates with and without antibiotics and 
incubated alongside the experimental plates. 
2.5.11 Colony Screening by Restriction Digest Analysis 
Four to six individual colonies from each LB agar plate containing transformed E. coli cells (Section 
2.5.10) were inoculated into separate 5 mL volumes of LB media containing appropriate 
antibiotics. Cells were cultured overnight at 37°C in a shaker incubator at 170 rpm. Cells were 
collected by centrifugation at 4 500 x g in a bench top centrifuge. Plasmid DNA was extracted 
using the GeneJET Plasmid Miniprep Kit (Thermo Scientific). The concentrations and purity of the 
extracted plasmids were determined on a NanoDrop ND-1000 spectrophotometer. The plasmids 
were subjected to restriction digest (Section 2.5.5) using the same restriction enzymes previously 
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used to digest the plasmid and insert. The digested DNA was separated by agarose gel 
electrophoresis and 10 µL of all positive plasmid clones were sent for sequencing at Inqaba 
Biotech Inc. (Cape Town, South Africa). The plasmids were sequenced using the Sanger chain 
sequencing method and results were analysed using SnapGene (GSL Biotech, USA) and ClustalW2 
multiple sequence alignment tools (Larkin et al., 2007).  
2.5.12 Recombinant Plasmids  
Table 6: Recombinant Plasmids and Restriction Enzymes Used in this Study 
Plasmid Restriction Enzymes Source 
pETM-30_imuA’L  NcoI, XhoI This study 
pETM-30_imuA’S NcoI, XhoI This study 
pETM-30_imuB NcoI, XhoI Jeremy Boonzaier (Depart-
ment of Biotechnology, 
UWC). 
pCOLD I_ imuA’L  KpnI, EcoRI This study 
pGEX-6P-2_imuA’S  HindIII, EcoRI This study 
 
 Recombinant Protein Production 
Plasmids with correct insert sequence as shown by the sequencing analysis were transformed 
into E. coli BL21 (DE3) cells for protein production. 
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2.6.1 Small Scale Protein Production Test 
Five millilitres of sterile LB media were added to four test tubes each as well as appropriate 
antibiotics to a final concentration of 100 µg/mL for ampicillin or 25 µg/mL for kanamycin. Each 
test tube was inoculated with a colony of E. coli BL21 (DE3) containing a recombinant plasmid 
with resistance to the antibiotic in the test tube. The inoculated test tubes were incubated 
overnight at 37°C with shaking at 170 rpm.  
Each overnight culture was used to inoculate 95 mL of LB media containing appropriate 
antibiotics in autoclaved Erlenmeyer flasks. The absorbance (OD600) of each inoculate was 
measured in a spectrophotometer and samples were diluted to OD600 = 0.1 with LB media. The 
cultures were incubated at 37°C and 170 rpm until the OD600 was between 0.4 and 0.6. Two 1 ml 
samples from each culture flask were transferred to Eppendorf tubes and frozen for SDS-PAGE 
analysis and glycerol stock preparation. Isopropyl β-D-1-thiogalactopyranoside (IPTG) at 0.5 mM 
final concentration was added to each culture flask for induction of recombinant gene 
expression. The culture flasks were transferred to different temperatures for overnight culturing 
as follows: Flasks with pETM-30_imuA’, pGEX-6P-2_imuA’, and pCOLD I_imuA’ were respectively 
cultured at 30°C, 25°C and 15°C. After 3 and 6 h, 1 mL samples were collected and stored for SDS-
PAGE analysis to record the rate of recombinant protein production.  
2.6.2  Harvesting Cells 
All 1 mL samples collected in section 2.6.1 were centrifuged in 1.5 mL Eppendorf tubes at 4 500 x g 
for 2 min in a bench top centrifuge. The overnight cultures were harvested in 50 mL centrifuge 
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tubes by centrifuging at 11 000 x g for 15 min at 4°C. Supernatants from centrifugation were 
discarded and the cells resuspended in lysis buffer.  
2.6.3 Cell Rupture  
The cells collected in Eppendorf tubes in section 2.6.2 were ruptured using BugBuster Protein 
Extraction Reagent (Merck Millipore). Cells were resuspended in BugBuster and incubated at 
room temperature for 20 min mixing gently on a roller mixer.  
Cells from the overnight cultures were resuspended in cooled lysis buffer and ruptured by 
sonication on ice using six cycles of 30 s sonication separated by 30 s breaks to prevent protein 
heat denaturation. Ruptured cells were centrifuged at 16 000 x g for 60 min at 4°C to separate 
soluble cellular content from insoluble content (pellets). 
2.6.4 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Analysis  
Soluble and insoluble fractions (pellets) were analysed by SDS-PAGE, which separates proteins 
by molecular weight in an electric field. Proteins were first denatured by boiling in the presence 
of a reducing agent and sodium dodecyl sulphate (SDS). Negatively charged SDS binds to the 
denatured proteins in proportion to their length resulting in an almost uniform charge-to-size 
ratio and allowing their separation within a porous polymer matrix. Protein samples are first 
concentrated in a stacking gel before being separated in a resolving gel with distinct pH, ionic 
strength and pore dimension (Laemmli, 1970). Ten microliters of each supernatant or soluble 
fraction (Section 2.6.3) was mixed with 2 µL of 8 x SDS-containing sample buffer and incubated 
at 95°C for 5 min to ensure complete protein denaturation. Pellets on the other hand were first 
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resuspended in lysis buffer containing 8 M urea to solubilize insoluble proteins and inclusion body 
proteins before adding 8 x SDS-containing sample buffer and boiling at 95°C for 5 min. 
For electrophoresis, the samples were loaded in wells of the stacking portion of gels and a 
constant current of 40 mA per gel applied for 45 min. The gels were stained for 15 to 20 min in 
Coomassie Brilliant Blue R-250 solution and excess stain removed by incubating in destaining 
solution overnight at room temperature. 
 Optimization for Soluble Protein Production 
2.7.1 Optimization of Culturing Temperature 
Five millilitres of an E. coli BL21 (DE3) cell culture  bearing either the plasmid pETM-30_imuA’S or 
pETM-30_imuA’L was used to inoculate 500 mL LB medium with 25 µɡ/mL kanamycin in a 2 L 
Erlenmeyer flask. The flask was incubated at 37°C and 170 rpm until the OD600 was between 0.6 
and 0.8. Each culture was divided into two 250 mL portions to test for protein production at 15°C 
and 25°C, respectively. Both cultured flask were induced for protein production with 0.5 mM 
IPTG and incubated overnight, one at 15°C and the other at 25°C in a shaker incubator at 170 
rpm. Cells were recovered by centrifuging at 11 000 x g for 15 min. The supernatant was 
discarded, pellets resuspended in lysis buffer and prepared for SDS-PAGE analysis (Section 2.6.4).  
2.7.2 Optimization of Gene Expression by IPTG 
A 300 mL culture of E. coli BL21 (DE3) transformed with pETM-30_imuA’S and cultured to OD600 
of 0.6 was divided into three equal fractions in 250 mL flasks and protein production induced by 
adding IPTG to a final concentrations of 0.05 mM, 0.1 mM and 0.25 mM, respectively. Flasks were 
incubated overnight at 20°C, centrifuged (11 000 x g for 15 min at 4°C), supernatant discarded 
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and pellets resuspended in lysis buffer. The resuspended pellets were lysed and analysed by SDS-
PAGE.  
2.7.3 ImuA’ Production in Optimized E. coli Strains  
The plasmid pETM-30_imuA’S was transformed into two specialized E. coli strains: Artic Express 
(Agilent Technologies) for low-temperature protein production and BL21-CodonPlus (Stratagene) 
which provides additional tRNAs of normally rare codons. Cells were cultured and induced with 
0.5 mM IPTG at OD600 of 0.6. After induction, Artic Express cells were incubated at 10°C and BL21-
CodonPlus cells at 15°C for 20 h at 170 rpm. Cells were separated from culturing media by 
centrifugation (11 000 x g for 15 min at 4°C) and resuspended in cell lysis buffer (Table 2). The 
resuspended cells were ruptured by sonication and analysed on SDS-PAGE gels. 
2.7.4  Optimization of Lysis Buffer pH 
E. coli BL21 (DE3) cells transformed with pETM-30_imuA’L recombinant plasmids were cultured 
and induced with 0.5 mM IPTG at 15°C. The cells were pelleted by centrifugation (11 000 x g for 
15 min at 4°C) and equal masses of pellets were resuspended and lysed in separate 15 mL tubes 
with Tris-HCl buffer at pH 7.0, 7.5, 8.0, 8.5, 9.0 and 9.5. The lysed cells were centrifuged at 
16 000 x g for 60 min at 4°C to separate soluble from insoluble fractions. The soluble and insoluble 
fractions were analysed by SDS PAGE. 
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 Solubilization of Inclusion Bodies and Protein Refolding 
2.8.1 Inclusion Body Preparation 
E. coli cells containing pETM-30_imuA’S were cultured, centrifuged and sonicated. Pellets were 
separated from the supernatant by centrifugation at 16 000 x g for 60 min at 4°C. The pellets 
were washed twice with wash buffer I (20 mM Tris pH 8 and 50 mM NaCl), centrifuged at 
16 000 x g for 1 h at 4°C. The supernatant was discarded and pellets were resuspended and 
washed twice with wash buffer II (50 mM Tris pH 8 50 mM NaCl, 2% Triton X-100, 1.5 mM 
β-mercaptoethanol and 1.6 mM urea). The pellets were washed once more with wash buffer I to 
remove triton X-100. 
2.8.2 Denaturation of Inclusion Body Proteins 
Washed inclusion bodies were dissolved in denaturing buffer (50 mM Tris pH 8, 50 mM NaCl, 
10 mM β-mercaptoethanol, 8 M urea) and stirred for 20 min. The resulting solution was 
centrifuged at 16 000 x g and 4°C for 1 h. The supernatant with solubilized inclusion body proteins 
was stored at 4°C for SDS-PAGE analysis. 
2.8.3 Protein Refolding by Dialysis  
The solubilized inclusion body proteins solution (30 mL) was transferred to a SnakeSkin Pleated 
Dialysis Tube (Thermo Scientific) with a molecular weight cut off (MWCO) of 3.5 kDa. The dialysis 
tube was immersed in 2 L of refolding solution (20 mM Tris pH 8, 100 mM NaCl, 6 M Urea and 
5 mM DTT) and stirred overnight with a magnetic stirrer at 4°C. The dialysis tube was transferred 
to a second (and third) refolding buffer with urea reduced to 4 (and 2) M urea and stirred for 10 h 
(overnight) at 4°C. The solution was clarified by centrifugation at 16 000 x g and 4°C for 1 h. The 
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supernatant was mixed with 2 mL of glutathione sepharose (GS) resin (GE Healthcare) previously 
washed with 2 CV of 2 M urea refolding solution. The resin-supernatant mixture was agitated 
overnight on a roller mixer at 4°C in a 50 mL Falcon tube. The mixture was transferred into an 
Econo-Pac chromatography column (Bio Rad, South Africa) and unbound proteins eluted. The 
resin was washed five times by refilling the column with wash buffer and allowing it to drain. All 
eluted fractions as well as a resin sample were analysed by SDS-PAGE to identify target protein 
potentially bound to resin or eluted. 
2.8.4 On-column Refolding 
Another sample of inclusion bodies was prepared and solubilized as described in Sections 2.8.1 
and 2. As described, the urea concentration of the solubilized protein was lowered to 4 M by 
repeated dialysis against 2 L of refolding solution with decreasing urea concentrations. The 
resulting solution was mixed with 2 mL Ni2+-NTA resin (Qiagen), poured into an Econo-Pac 
chromatography column and washed with 4 M urea refolding buffer. The protein-resin mixture 
was agitated overnight on a roller mixer at 4°C. The resin was washed successively with 
five column volumes (CV) of 2 M urea-containing refolding solution and with 2 CV of 10 mM, 
25 mM and 60 mM imidazole-containing refolding solution. The resin was further washed with 
100 mM and 300 mM imidazole-containing refolding solution to elute proteins from resin. 
Samples of the wash fraction, the elution fraction and the resin after elution were analysed by 
SDS-PAGE. The resin was incubated overnight in 10 mL of 300 mM imidazole-containing refolding 
buffer and washed with 2 CV of 500 mM imidazole-containing refolding buffer to elute protein 
of interest that was still bound on the resin. 
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  Co-transformation and Production of ImuA’S and ImuB 
Plasmids of pCOLD I_imuA’L (this work) and pETM-30_imuB (provided by Mr Jeremy Boonzaier, 
Structural Biology Laboratory, University of the Western Cape) were co-transformed into E. coli 
BL21 (DE3) and cultured overnight on an LB plate containing ampicillin and kanamycin. A colony 
from the plate was used to inoculate 5 mL LB media containing 100 µɡ/mL ampicillin and 
25 µɡ/mL kanamycin. The culture was incubated at 37°C overnight with shaking at 170 rpm. The 
culture was then transferred to 45 mL of LB with the same concentrations of antibiotics and 
incubated at 37°C with shaking at 170 rpm until the OD600 was between 0.6 and 0.8. Protein 
production was induced by the addition of 0.5 mM IPTG and the culture incubated with shaking 
overnight at 15°C and 170 rpm. The next morning, the cell culture was centrifuged, the 
supernatant discarded and the pellets resuspended in lysis buffer. The resuspended cells were 
ruptured by sonication, centrifuged (11 000 x g for 1 h at 4°C) to separate soluble from insoluble 
fractions and both fractions analysed by SDS-PAGE. 
  Modelling the Three-Dimensional Structure of ImuA’L 
Homology or comparative modelling is a technique used to infer the structure of a target protein 
based on the experimentally determined structure of a template by analogy. The technique 
generally involves four steps: i) template identification, ii) target–template alignment, iii) model 
building, and iv) model assessment. In identifying a template, a library of experimentally 
determined protein structures is searched using the sequence of the protein of interest (target) 
to identify proteins with significant sequence identity to the target. The protein with highest 
sequence identity and sequence coverage is selected and aligned with the target. Using the 
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sequence alignment and the coordinates of the template structure, the sequence of the target 
protein is threaded onto the existing backbone. Insertions and deletions are accommodated 
where possible. An energy minimization step allows high-energy artifacts from the modelling 
step to be eliminated. Finally the model quality is assessed by comparing backbone conformation 
and side-chain packing to chemical standards. 
Protein sequences from the UniProtKB/Swiss-Prot database homologous to ImuA’L were 
identified using NCBI-BLAST (Ye et al., 2006). The sequences of ImuA’L and the protein structure 
with highest sequence identity to ImuA’L were aligned using ClustalW2. The alignment was 
uploaded to the Workspace Alignment Mode on the SWISS-Model server (Kiefer et al., 2009), to 
force the server pipeline to construct the model structure strictly on the alignment by segment 
matching or coordinate reconstruction. Minor modifications are made to accommodate 
deletions and insertions. The model was evaluated and plots of Anolea mean force potential, 
GROMOS empirical force field energy and Verify3D profile evaluation produced to judge the 
quality of model and template structures. 
The graphics program Pymol was used to read protein coordinate files of model and template 
structures (The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.).  
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3 Results 
The working hypothesis at the inception of this project was that ImuB interacts with ImuA’ and 
DnaE2 (ImuC) to form a molecular complex necessary for translesion synthesis in Mtb. This 
molecular complex would access DNA lesions through the interaction of ImuB and the β-clamp 
protein on the DNA (Figure 1) (Ndwandwe, 2013). The role of ImuA’ in this complex, however, 
remains unknown. This study was aimed at structurally analysing ImuA’ to help unravel its 
function during translesion synthesis. The strategy was therefore to design primers for PCR 
amplification of imuA’ from Mtb genomic DNA, clone the PCR products into protein production 
plasmids for recombinant protein production in E. coli, purify the protein using chromatographic 
techniques, crystallize and solve the protein crystal structure using X-ray crystallographic 
methods.  
 
Figure 1: DnaE2-dependent mutagenesis in Mtb. According to this model, DNA damage causes normal 
replication to stall. In turn, expression of dnaE2, imuB and imuA’ is up-regulated allowing the resulting 
proteins to be recruited to the site of the lesion. DnaE2 and ImuA’ presumably access the DNA template 
by interacting with ImuB, which binds the β-clamp protein on the DNA. The complex once formed 
catalyses translesion synthesis across the lesion. 
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 Cloning imuA’ into Protein Production Plasmids 
3.1.1 Sequence Acquisition and Naming  
The CMI JCVI database (cmr.jcvi.org/cgibin/CMR/shared/GenePage.cgi?locus=NTL02MT03387), 
provided two sequences for imuA’ differing with respect to the 5’-terminal start. Alternative 
promoters and start codons thus appear to exist for this gene. In the following, the two sequences 
are denoted imuA’S and imuA’L, where S and L indicate “short” and “long” respectively. The 
imuA’L sequence adds 270 bp to the 5’-end of imuA’S (Figure 2). 
 
 
 
imuA'S          ------------------------------------------------------------ 
imuA'L          GTGCCGGTTAGTGCGATAGTCGCAACGGCCGGTAGCTCGAACCCATCGGTGGTGTTGTCG 60                                                            
imuA'S          ------------------------------------------------------------ 
imuA'L          GTGGCGAAGAGCTCTGCCGGCCGGCAGGCAGGCCCGCCACCGGTGGCCGGTGGGGCCGTC 120                                                                            
imuA'S          ------------------------------------------------------------ 
imuA'L          CCTGGGCCTAACAGGCCGCAAAACAGCAGGGCAGCCGCCAGTACCGAGGTGGTTTTACGC 180                                                                             
imuA'S          ------------------------------------------------------------ 
imuA'L          GATTGCACAAGGCAGCCTCTCATGACCTTGACGGACTCCAAGGACGGGTGTTTACTGACT 240                                                                             
imuA'S          ------------------------------ATGACTGCGGCCTTCGCCTCCGACCAACGC 30 
imuA'L          TCGAACATATTTTCGAACAGGAGGCTGGTCATGACTGCGGCCTTCGCCTCCGACCAACGC 300 
                                              ****************************** 
imuA'S          CTTGAAAATGGTGCTGAGCAGCTCGAATCACTACGACGGCAGATGGCTTTGCTGTCCGAG 90 
imuA'L          CTTGAAAATGGTGCTGAGCAGCTCGAATCACTACGACGGCAGATGGCTTTGCTGTCCGAG 360 
                ************************************************************ 
imuA'S          AAGGTGTCCGGGGGGCCCAGCCGTTCGGGCGACCTGGTGCCGGCGGGACCGGTGTCGTTG 150 
imuA'L          AAGGTGTCCGGGGGGCCCAGCCGTTCGGGCGACCTGGTGCCGGCGGGACCGGTGTCGTTG 420 
                ************************************************************ 
imuA'S          CCCCCGGGGACGGTGGGAGTGCTGTCGGGTGCGCGGTCACTGCTGCTGAGCATGGTGGCA 210 
imuA'L          CCCCCGGGGACGGTGGGAGTGCTGTCGGGTGCGCGGTCACTGCTGCTGAGCATGGTGGCA 480 
                ************************************************************ 
imuA'S          TCGGTGACGGCGGCCGGGGGAAACGCGGCCATCGTTGGCCAGCCGGATATCGGGTTGCTG 270 
imuA'L          TCGGTGACGGCGGCCGGGGGAAACGCGGCCATCGTTGGCCAGCCGGATATCGGGTTGCTG 540 
                ************************************************************ 
imuA'S          GCCGCGGTGGAGATGGGGGCGGATCTGAGCCGGCTCGCGGTGATACCAGATCCCGGGACC 330 
imuA'L          GCCGCGGTGGAGATGGGGGCGGATCTGAGCCGGCTCGCGGTGATACCAGATCCCGGGACC 600 
                ************************************************************ 
imuA'S          GATCCGGTTGAGGTGGCCGCTGTGCTGATCGACGGCATGGATCTGGTGGTGCTCGGTCTG 390 
imuA'L          GATCCGGTTGAGGTGGCCGCTGTGCTGATCGACGGCATGGATCTGGTGGTGCTCGGTCTG 660 
                ************************************************************ 
imuA'S          GGAGGGCGCCGGGTGACGCGGGCGCGGGCGCGGGCAGTGGTGGCCCGTGCCCGTCAAAAA 450 
imuA'L          GGAGGGCGCCGGGTGACGCGGGCGCGGGCGCGGGCAGTGGTGGCCCGTGCCCGTCAAAAA 720 
                ************************************************************ 
imuA'S          GGCTGCACCCTGCTGGTCACCGACGGCGACTGGCAAGGCGTGTCGACGCGGCTTGCGGCC 510 
imuA'L          GGCTGCACCCTGCTGGTCACCGACGGCGACTGGCAAGGCGTGTCGACGCGGCTTGCGGCC 780 
                ************************************************************ 
imuA'S          CGGGTCTGCGGCTATGAGATCACCCCGGCCCTCAGGGGCGTGCCCACCCCGGGGTTGGGG 570 
imuA'L          CGGGTCTGCGGCTATGAGATCACCCCGGCCCTCAGGGGCGTGCCCACCCCGGGGTTGGGG 840 
                ************************************************************ 
imuA'S          CGGATCAGTGGGGTGCGGCTGCAGATCAACGGGCGTGGACGGTGA 615 
imuA'L          CGGATCAGTGGGGTGCGGCTGCAGATCAACGGGCGTGGACGGTGA 885 
                ********************************************* 
 
Figure 2: Alignment of imuA’S and imuA’L. The imuA’L sequence is 5’-terminally 
extended by 270 bp relative to imuA’S: bold nucleotides marked by the blue bracket 
and alternating with dashed lines. Aligned with ClustalW2 (Larkin et al., 2007). 
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3.1.2 Sequence Analysis for GC Content and Rare Codons  
As the Mtb genome is characteristically GC-rich, the two sequences for imuA’ were analysed for 
their guanine and cytosine (GC) content and for rare codons. GC-rich genes often form inter- and 
intra-strand secondary structures (hairpins) due to increased hydrogen bonding between 
guanines and the N-7 rings of neighbouring guanines causing premature termination during PCR 
and correspondingly smaller bands in electrophoresis (Jesen et al., 2010). High melting 
temperature overlaps between template and compliment strands additionally cause mis-priming 
and -annealing in GC-rich genes. The respective GC-content of imuA’S and imuA’L is 70 and 68% 
(http://www.endmemo.com/bio/gc.php).  
Organisms use 61 of 64 possible nucleotide codons to code for amino acids, two for stop codons 
and one for the N-terminal formyl-methionine. Depending on the organism, some codons for a 
particular amino acids are used more frequently (major codons) than others (rare codons). 
Fifteen codons classified as rare in E. coli were identified in imuA’L 
(http://nihserver.mbi.ucla.edu/RACC/) (highlighted in Figure 3).  
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Figure 3: The DNA sequence for Mtb imuA’L highlighting rare codons with respect to translation in E. coli. 
Rare codons for arginine, leucine, isoleucine, and proline are respectively coloured red, green, blue and 
orange 
 
3.1.3 PCR Amplification of imuA’S and imuA’L 
Amplification of imuA’ proved a major challenge in this project. Initially, PCR primers for 
amplification of imuA’S using a standard three-step PCR method (section 2.5.2.1) were designed. 
These primers had one or two guanines (G) or cytosines (C) at their 3’-ends to ensure tight binding 
of primer to template. However, agarose gel electrophoresis showed truncated bands smaller 
than the anticipated size of imuA’S. The bands were isolated, sequenced and found to be 
truncated imuA’S. The sequenced gene also showed that the 3’ G or C of the primers cause 
unspecific priming probably because of the high GC content of the gene. The specificity of the 
gtg ccg gtt agt gcg ATA gtc gca acg gcc ggt agc tcg aac cca tcg gtg gtg ttg tcg gtg gcg aag agc tct 
gcc ggc cgg cag gca ggc ccg cca ccg gtg gcc ggt ggg gcc gtc cct ggg cct aac AGG ccg caa aac agc AGG 
gca gcc gcc agt acc gag gtg gtt tta cgc gat tgc aca AGG cag cct ctc atg acc ttg acg gac tcc aag gac 
ggg tgt tta ctg act tcg aac ATA ttt tcg aac AGG AGG ctg gtc atg act gcg gcc ttc gcc tcc gac caa cgc 
ctt gaa aat ggt gct gag cag ctc gaa tca CTA CGA cgg cag atg gct ttg ctg tcc gag aag gtg tcc ggg ggg 
CCC agc cgt tcg ggc gac ctg gtg ccg gcg gga ccg gtg tcg ttg CCC ccg ggg acg gtg gga gtg ctg tcg ggt 
gcg cgg tca ctg ctg ctg agc atg gtg gca tcg gtg acg gcg gcc ggg gga aac gcg gcc atc gtt ggc cag ccg 
gat atc ggg ttg ctg gcc gcg gtg gag atg ggg gcg gat ctg agc cgg ctc gcg gtg ATA cca gat CCC ggg acc 
gat ccg gtt gag gtg gcc gct gtg ctg atc gac ggc atg gat ctg gtg gtg ctc ggt ctg gga ggg cgc cgg gtg acg 
cgg gcg cgg gcg cgg gca gtg gtg gcc cgt gcc cgt caa aaa ggc tgc acc ctg ctg gtc acc gac ggc gac tgg 
caa ggc gtg tcg acg cgg ctt gcg gcc cgg gtc tgc ggc tat gag atc acc ccg gcc ctc AGG ggc gtg CCC acc 
ccg ggg ttg ggg cgg atc agt ggg gtg cgg ctg cag atc aac ggg cgt gga cgg tga 
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primers was thus modified by ensuring they end in adenosine (A) or thymine (T) at the 3’-end 
(Table 3). However, standard PCR (section 2.5.2.1) still did not amplify the imuA’S gene using 
these modified primers. Using Phusion High Fidelity DNA polymerase (Finnzymes), designed for 
amplification of GC-rich genes, with the 3’-GC primers and 3’-AT primers in a standard PCR 
protocol again yielded truncated gene products for both sets of primers. Also repeating the 
amplification using annealing temperatures of 50, 56, 60 and 65°C or gradient PCR (section 
2.5.2.2) with annealing temperature between 52 and 68°C at 2°C intervals did not yield the 
expected PCR products.  
As mis-priming and mis-annealling can be caused by high primer melting temperatures, 
overriding the annealing temperature step was considered. Two-step PCR (section 2.5.2.3) in 
which the annealing temperature step is eliminated was therefore applied yielding full-length 
imuA’S and imuA’L products for the 3’-AT primers. The method was repeated to amplify imuA’S 
and imuA’L for cloning into pETM-30 and pCOLD I and pGEX-6P-2 vectors (Figure 4).  
A     B    C 
  
Figure 4: Agarose gels depicting the results of ‘two-step’ PCR amplification of imuA’S and imuA’L from Mtb 
genomic DNA. A) Amplification products of imuA’S and imuA’L for cloning into pETM-30: Lanes 2 and 3: 
imuA’S and imuA’L PRC products, respectively. B) Amplification products of imuA’L for cloning into 
pCOLD I: Lane 2: Negative control, PCR mix without the genomic DNA; Lane 3 and 4: PCR product of 
imuA’L. C) Amplification of imuA’S for cloning into pGEX-6P-2: Lanes 2 and 3: PCR products of imuA’S. 
Lanes 1 in A, B and C: GeneRuler 1 kb DNA ladder with sizes as indicated to the left of the gel.  
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3.1.4 Colony Screening by Restriction Enzyme Double Digestion 
The PCR products (Figure 4) and the target vectors were digested using appropriate restriction 
enzymes (section 2.5.5). The plasmids and inserts were ligated using T4 DNA ligase, transformed 
into competent E. coli DH5α cells and plated on agar plates with appropriate antibiotic. Only cells 
carrying the plasmids with an antibiotic resistance gene grew on agar plates while control plates 
with antibiotic and plated with un-transformed competent cells showed no growth. Occasionally, 
plasmids digested with two restriction enzymes may circularize without an inserted gene. Cells 
taking up such plasmids will grow on antibiotic plates as false positive colonies. To distinguish 
false and true positive colonies, plasmids were extracted and digested with appropriate 
restriction enzymes (Figure 5). 
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Figure 5: Screening colonies for positive imuA’ clones by restriction digest of recombinant plasmids. Lanes 
M: GeneRuler 1 kb DNA ladder with sizes as indicated to the left of the gel. A): Restriction digest of 
recombinant pETM-30_imuA’ plasmids isolated from transformed clones. Lane 1: Undigested plasmid; 
Lanes 2-5: XhoI and NcoI digest of pETM-30_imuA’S plasmids from four distinct colonies. Lanes 6-9: XhoI 
and NcoI digest of pETM-30_imuA’L from four distinct colonies. The undigested plasmid band in Lane 1 is 
characteristically smeared presumably due to plasmid DNA supercoiling. The original imuA’S insert can 
clearly be seen after restriction digest in lanes 2 to 5: (red rectangle) implying that all four colonies contain 
the insert imuA’S. The remaining plasmid, however, smeared out possibly due to shearing of the plasmid 
or high salts concentration in the digestion buffers used. Lanes 6 and 9 contain the imuA’L insert (red 
rectangles) while lanes 7 and 8 are false positive colonies. B): Lanes 1-3 and lanes 5-7: EcoRI and KpnI 
restriction digest of recombinant pCOLD I_imuA’L isolated from transformed clones. Lane 4: Empty. Lanes 
1 and 6 show true positive clones with the imuA’L insert band indicated by red rectangles. Lanes 2 shows 
a false positive clone with just the plasmid band and no insert. Lanes 3, 5 and 7 are smeared out possibly 
due to shearing of DNA or high concentration of salts in buffer, no band could be identified. C): Lanes 1, 
2, 4 and 5: EcoRI and XhoI double restriction digest of pGEX-6P-2_imuA’S plasmids isolated from 
transformed clones. Lane 3: imuA’S PCR product as size marker. Lanes 1, 2 and 5 showed true positive 
clones as identified by the insert bands (red rectangles). The remaining plasmids in lanes 1 and 5, however, 
smeared out and could not be identified on the lane. Lane 4 shows a false positive colony as only the 
plasmid band was identifiable. Lane 3, the positive control band runs lower than the other insert bands. 
This could be due to the higher concentration of DNA in the control band. All true positive colonies were 
Sanger sequenced (Inqaba Biotech Inc.) and confirmed to be imuA’ clones. 
 
A 
B 
C 
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3.1.5 Sequencing of Positive Recombinant Plasmids 
True positive recombinant plasmids (Figure 5) were further confirmed by sequencing the 
recombinant plasmids (Inqaba Biotech). The experimentally determined nucleotide sequences of 
pETM-30_imuA’L corresponding to isolates seen in Figure 5A, Lanes 6 and 9 are compared to the 
theoretical imuA’L sequence in Figure 6. The experimental imuA’L nucleotide sequences aligned 
to the database sequence within the restriction cut sites as indicated on the Figure 6. All other 
colonies identified as true positives in Figure 5 were similarly sequenced and aligned. Constructs 
with mutations were discarded. 
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Figure 6: Nucleotide sequence alignment of pETM-30_imuA’L from two true positive colonies (Figure 5B, 
Lanes 6 (L1) and 9 (L4)) with the database derived imuA’L sequence. Asterisks mark nucleotides identical 
between the experimental and database sequences. 
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 Properties of ImuA’L and ImuA’S 
Physical molecular properties calculated for ImuA’L and ImuA’S are contrasted in Table 7. 
Table 7 : Molecular properties determined for ImuA’L and ImuA’S 
Property ImuA’L ImuA’S 
Gene length (bp) 885 615 
Protein length (AA) 294 204 
Molecular weight (kDa) 29.9 20.8 
pI 11.2 10.7 
Instability index 44.1 34.0 
Aliphatic index 99.5 106.6 
% Solubility in E. coli 3.6  6.7  
 
 Production of Recombinant ImuA’ in E. coli 
Structural studies of proteins by X-ray crystallography generally require the production and 
purification of milligram amounts of the protein. In this study, four recombinant plasmids were 
constructed for overexpression of imuA’ in E. coli. The plasmids: pETM-30, pCOLD I and 
pGEX-6P-2 were used to generate four recombinant constructs: pETM-30_imuA’S, 
pETM-30_imuA’L, pCOLD I_imuA’L and pGEX-6P-2_imuA’S. The pET plasmid has a T7 promoter 
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upstream of a multiple cloning site, into which the gene of interest is inserted. The promoter 
ensures high levels of gene expression in the presence T7 RNA polymerase inducible from the 
chromosomal DNA of E. coli BL21 (DE3) strains by inducers like IPGT. For its part, the pGex vector, 
transcribed by prokaryotic RNA polymerases contains a tac promoter under the control of a lacI 
operator inducible by IPTG. Additionally, each plasmid has an affinity tag, which allows the 
protein to be produced as a fusion protein with the tag at its either N- and/or C-terminus. The 
affinity tag is useful for downstream protein purification by affinity chromatograph.  
The pETM-30 vector has a gst gene for the production of an N-terminally GST-tagged protein. It 
also encodes both an N- and C-terminal His6-tag. These tags make it possible to purify the protein 
in two rounds of affinity chromatography. Here, the proteins were immobilised on Ni-NTA resin, 
washed with imidazole containing wash buffer and then eluted with high concentrations of 
imidazole (250 mM imidazole).  
The vector pETM-30 does not encode a protease cleavage site for the C-terminal His6-tag. The 
tag can potentially impair downstream processes such as crystallization. Hence imuA’S was also 
cloned into pGEX-6P-2 vector, which adds an N-terminal GST-tag separated from the protein by 
a PreScission Protease cleavage site.  
Some proteins tend to be packaged in inclusion bodies when overexpressed in E. coli. The pCOLD I 
vector, a cold shock expression vector, was used to clone imuA’L for protein production at low 
temperatures. The low temperature slows the rate of protein production, potentially helping the 
protein to fold properly. The protein of interest is N-terminally His6-tagged when produced from 
the pCOLD I vector.  
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The plasmid DNA constructs were sequenced and those with no mutations in the DNA were 
transformed into E. coli BL21 (DE3) cells for small scale protein production (Section 2.6.1).  
3.3.1 Production of GST-ImuA’S and GST-ImuA’L 
E. coli BL21 (De3) cells transformed with pETM-30_imuA’S and pETM-30_imuA’L were separately 
cultured in LB medium and induced with 0.5 mM IPTG for overnight protein production. The 
cultures were analysed the following day by SDS-PAGE (Figure 8). It was observed that both 
proteins were produced but the proteins were in the insoluble fraction. 
  
Figure 7: GST-ImuA’L produced in E. coli BL21 (DE3) cells following incubation at 30°C and induction with 
0.5 mM IPTG. Lane M: Unstained Protein Molecular Weight Marker (Thermo Scientific); Lanes 1 and 2: 
Complete cells prior to addition of IPTG for protein production; Lanes 3 and 4: Soluble cell fractions of 
GST-ImuA’L and GST-ImuA’S after overnight induction; Lanes 5 and 6: Insoluble fractions of GST-ImuA’L 
and GST-ImuA’S. The protein produced is largely insoluble as indicated by the bands on lane 5 and 6 in 
the red box.  
 
As the protein was predominantly insoluble, the induction conditions were varied to potentially 
increase the proportion of soluble protein (Section 2.7). First, the induction temperature was 
reduced to 25°C and 15°C, to enhance protein folding and solubilisation. The rate of protein 
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production at these lower temperatures was monitored by collecting samples after 2, 3, 4, and 
6 h as well as overnight following induction with IPTG. However, temperature optimization did 
not visibly increase the proportion of soluble protein (Figure 9). 
 
Figure 8: GST-ImuA’ production from pETM-30_imuA’S and pETM-30_imuA’L plasmids in E. coli BL21 (DE3) 
cells at 15°C and 25°C, 0.5 mM IPTG. Lane M: Unstained Protein Molecular Weight Marker (Thermo 
Scientific); Lane 1: Uninduced fraction; Lanes 2 to F: soluble fractions, Lanes G to K: insoluble fractions; 
Lanes 2-5: GST-ImuA’S produced at 15°C, 2, 4, 6 and 15 h after induction; Lane 6-9: GST-ImuA’L produced 
at 15°C, 2, 4, 6  and 15 h after induction; Lanes A-C: GST-ImuA’S produced at 25°C and 3, 6 and 15 h after 
induction; Lane D-F: GST-ImuA’L produced at 25°C, 3, 6 and 15 h after induction. Lane G: Insoluble fraction 
before induction. Lane H: GST- ImuA’S after overnight induction at 15°C; Lane I: Insoluble fraction of 
GST- ImuA’L after overnight induction at 15°C; Lane J: Insoluble fraction of GST- ImuA’S after overnight 
induction at 25°C; Lane K: insoluble fraction of GST-ImuA’L after overnight induction at 25°C. The red box 
shows protein in the insoluble fractions.  
The rate of induction was optimized by varying the IPTG concentration (Section 2.7.2) and 
temperature together. Protein production was induced at 15°C with 0.05, 0.1, and 0.25 mM IPTG 
and analysed after 6 h and overnight incubation (Figure 9). The protein was still observed to 
overwhelmingly occur in the insoluble fractions. 
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Figure 9: GST-ImuA’S produced from pETM-30_imuA’S construct in E. coli at 15°C induced with varying 
IPTG concentrations. A): Lane 1: Soluble fraction before induction with IPTG; Lane 2: Soluble fraction after 
0.05 mM IPGT induction; Lane 3: Insoluble fraction before induction; Lane 4: Insoluble fraction after 
induction with 0.05 mM IPTG. B): lane 1: Soluble fraction after 6 h induction with 0.1 mM IPTG; Lane 2: 
Soluble fraction after overnight induction with 0.1 mM IPTG; lane 3 and lane 4: Corresponding insoluble 
fractions of lane 1 and 2; Lane 6 and 7: 6 h and overnight soluble fractions induced with 0.25 mM IPTG; 
Lane 8 and 9: Corresponding insoluble fractions of lanes 6 and 7; N: Lanes that were not loaded with 
protein. GST-ImuA’S in the insoluble fractions are indicated with red rectangles. Lanes M: Odyssey Protein 
Molecular Weight Marker (Li-Cor). 
 
3.3.2 Production of ImuA’ from pGEX-6P-2 and pCOLD I Vectors 
The pGEX vector system is a classic system to produce proteins in E. coli. The vector encodes an 
N-terminal GST-tag that acts as a solubility partner to some insoluble proteins. Since the vector 
pETM-30 used initially for ImuA’ production had both C- and N-terminal His6-tags, which could 
interfere with protein folding and solubility, the genes of interest were cloned into pGEX-6P-2 
and the resulting construct used to produce ImuA’S. The plasmid clone pGEX-6P-2_imuA’S was 
transformed in E. coli BL21 (DES) cells, cultured at 25°C and induced for protein production with 
0.5 mM IPTG. Protein production was analysed by SDS-PAGE (Figure 10). 
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Figure 10: Production of ImuA’S as a recombinant GST-fusion protein from pGEX-6P-2_imuA’S in E. coli. 
Lane M: PageRuler Unstained Protein Ladder (Thermo Scientific); Lane 1: Whole cell fraction of sample 
before induction; Lanes 2 to 4: Soluble fractions 3, 6 and 16 h after induction with 0.5 mM IPTG. Lane 5 to 
7: Insoluble fractions corresponding to lanes 2 to 4. The red rectangle in lanes 5 to 7 marks the successful 
production of recombinant but insoluble GST-ImuA’S fusion protein.  
 
As both pETM-30 and pGEX-6P-2 vectors successfully expressed imuA’ but resulted in insoluble 
protein, the vector pCOLD I, a cold shock vector specially designed to increase solubility of 
proteins by producing them at low temperatures in E. coli, was used. The imuA’L gene was ligated 
into pCOLD I, transformed in E. coli BL21 (DE3) cells, cultured and induced with 0.5 mM IPTG for 
protein production at 15°C. Protein production was analysed by SDS-PAGE (figure 11). 
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Figure 11: ImuA’L produced from pCOLD I_imuA’L construct as a recombinant His6-tagged protein in 
E. coli. Lane 1: Sample before induction; Lane 2-4 Samples collected 3, 6 and 16 h after induction with 0.5 
mM IPTG. Lane 6: Insoluble fraction before induction. Lane 7-9: Insoluble fractions corresponding to 
Lanes 2-4. Lane M: PageRuler Unstained Protein Ladder (Thermo Scientific). The protein band in the red 
box indicates insoluble His6-ImuA’L.  
 
3.3.3 Optimization of Lysis Buffer 
The recombinant protein produced from all plasmids described up to this point using different 
induction conditions are essentially produced insolubly. Leibly (2012) hypothesized that a 
significant proportion of protein in insoluble fractions are originally soluble proteins that 
aggregate during cell lysis. Appropriate lysis buffers could prevent aggregation of soluble protein 
or solubilise partly aggregated protein. This hypothesis was investigated by using different lysis 
buffers to increase the yield of soluble Mtb proteins (Singh et al., 2011). Buffer parameters tested 
included varying pH (6-9), the NaCl concentration (100-500 mM) and detergents to solubilise the 
 
 
 
 
47 
 
three insoluble Mtb proteins. Here, lysis buffers at different pH were used to support ImuA’ 
solubility. However, the protein remained insoluble (Figure 12). 
 
Figure 12: Attempted solubilisation of ImuA’L by varying the pH of the lysis buffer. Lane 1: Uninduced 
soluble fraction; Lane 2-7: Soluble fractions of ImuA’L lysed in Tris HCl buffer at pH 7, 7.5, 8, 8.5, 9, and 
9.5 respectively; Lane 8-14: Corresponding insoluble fractions of Lane 2-7; Lane N: No protein. The protein 
remained insoluble (red rectangle). 
 
3.3.4 Protein Production in E. coli BL21-CodonPlus Cells 
Sequence analysis identified 15 E. coli rare codons in imuA’ (Figure 3). The E. coli BL21-CodonPlus 
strain, optimised to provide tRNAs for rare E. coli codons, was used for ImuA’S production 
(Section 2.7.3). SDS-PAGE analysis, however, did not reveal either soluble or insoluble ImuA’S 
(Figure 13). 
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Figure 13: Production of GST-ImuA’S in BL21-CodonPlus cells. No visible GST-ImuA’S band is seen at the 
correct size (black line).  
 
 Solubilization and Refolding of GST-ImuA’S from Inclusion Bodies 
To obtain functional protein from inclusion bodies, the target protein must first be solubilised 
and then refolded. First, the insoluble cell fraction encompassing inclusion bodies mixed with cell 
membranes is washed and proteins solubilised with buffers containing high chaotrope 
concentrations such as urea or guanidine HCl. Solubilized but unfolded proteins are then purified 
by liquid chromatography and allowed to refold to their original native conformation by reducing 
the denaturant concentration. Here, 8 M urea was used to solubilise GST-ImuA’S from inclusion 
bodies. Two refolding techniques were attempted for ImuA’S: refolding by dialysis and on-
column refolding (section 2.8.3 and 4). 
To refold a denatured protein by dialysis, the solubilised protein is dialyzed against a sequence 
of buffers with stepwise lower denaturant concentrations (Section 2.8.3). At 2 M urea 
concentration, white precipitate was observed in the protein solution indicating aggregation. The 
solution was centrifuged to remove the precipitate from potentially soluble protein that could 
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bind to GS-resin for purification by GST-affinity chromatography. GST-ImuA’S was, however, not 
observed to bind when analysing SDS PAGE, indicating that it had quantitatively precipitated.  
3.4.1 On-column Refolding 
For on-column refolding, the solubilised inclusion body solution was incubated with Ni-NTA resin 
to allow the protein to bind through its His6-tag. The resin was then washed with buffers 
containing step-wise lower urea concentrations to potentially allow the protein to fold isolated 
from other protein molecules to prevent aggregation (Section 2.8.4). The protein was finally 
eluted with 2 M urea refolding buffer supplemented with 300 mM imidazole and analysed by 
SDS-PAGE (Figure 14). 
 
 
 
 
 
 
Figure 14: On-column refolding of GST-ImuA’S from inclusion bodies. Lane 1: Insoluble GST- ImuA’L as size 
marker; Lane 2: slightly smaller GST-ImuA’S solubilized in 8 M urea and dialyzed to 4 M urea. Lane 3: Ni-
NTA resin before adding the protein sample; Lane 4: Mixture of resin and protein sample; Lane 5-11: Wash 
fractions; Lane 12: Resin after removal of unbound protein. ImuA’S is seen to remain bound to the beads; 
Lane 13: Eluate after incubating the ImuA’-loaded resin in 300 mM imidazole overnight; Lane 14-15: Elution 
fractions with 500 mM imidazole; Lane 16: Resin after 500 mM imidazole wash to elute GST-ImuA’S. The 
GST-ImuA’S protein remains bound to the resin. 
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 Co-production of His6-ImuA’L and GST-ImuB 
Based on the fact that ImuA’ is known to interact with ImuB (Figure 1) (Warner et al., 2010), we 
inferred that stability and hence solubility of ImuA’ could be dependent on ImuB. To verify this 
hypothesis, two vector constructs, pCOLD I_imuA’L and pETM-30_imuB (provided by Jeremy 
Boonzaier, fellow MSc. student, University of the Western Cape) were co-transformed into E. coli 
BL21 (DE3) cells. Protein production was induced with 0.5 mM IPTG for both proteins (Section 
2.8). The resulting cells were lysed and soluble protein production was verified by Ni-NTA affinity 
chromatography (figure 15). The SDS-PAGE analysis revealed a protein band at the size of ImuA’L 
in the soluble fraction. However, this protein failed to bind to the Ni-NTA resin.   
 
Figure 15: Co-production of His6-ImuA’L and GST-ImuB: Lane 1: Whole cell fraction; Lane 2: Soluble 
fraction; Lane 3: Insoluble fraction; Lane 4: Ni- NTA resin prior to adding the soluble cell fraction; Lane 5: 
Ni-NTA resin plus soluble fraction; Lane 6-9: Wash fractions with 10, 20, 50, and 250 mM imidazole; Lane 
10: Resin after washing with 250 mM imidazole. Co-producing ImuA’L and ImuB does produce soluble 
ImuA’L (red arrow). This protein, however, did not bind to Ni-NTA resin. Red rectangle: His6-ImuA’L; green 
rectangle: insoluble GST-ImuB.  
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 Modelling the Three-Dimensional Structure of ImuA’L 
Three dimensional (3D) structures are invaluable sources of information for protein 
structure/function relationships. Though best determined experimentally by X-ray 
crystallography, nuclear magnetic resonance spectroscopy or electron microscopy, any one of 
the steps required to achieve the final aim, including protein production, purification and 
stability, may fail, preventing the desired outcome. In the absence of experimental structures, a 
homology model of the protein in question can still provide useful information. In this project, 
the experimental structure determination of ImuA’ by X-ray crystallography was impeded by 
problems in folding and the resulting insolubility of ImuA’. A model structure of ImuA’L was 
instead generated using the SWISS-MODEL, a web-based protein modelling server. Four steps 
were required: First, a protein BLAST search of the UniProtKB/Swiss-Prot database with ImuA’L 
as the target returned 15 partly homologous protein sequences (Figure 16). ImuA’S is listed as 
the best hit with a sequence identity of 100% (narrow red line). However, the lack of an 
experimental structure precludes its use. The next hit, an ATP-dependent helicase with a 
sequence coverage of 54% and E-value of 0.22 was also excluded due to the lack of an 
experimental structure. The next three hits from the ATP-dependent hit were RecA proteins. 
Though without experimental structures themselves, crystal structures of homologues from E. 
coli and M. smegmatis have been determined. Their PDB codes are 3CMW and 1UBC, 
respectively. M. smegmatis RecA crystal structure was chosen for homology modelling of ImuA’L 
over the E. coli RecA for two reasons: first, ImuA’L and 1UBC are both mycobacterial proteins and 
may evolutionally be more closely related that the E. coli counterpart; second, the crystal 
structure of E. coli RecA is solved in complex with DNA potentially altering the solution structure 
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of the protein. M. smegmatis RecA and ImuA’L were aligned using the NCBI BLAST alignment tool. 
The alignment showed significant homology with an E-value of 7x10-5 and a sequence identity of 
32%. The sequence coverage is only 23% implying that structural information is limited to around 
a quarter of ImuA’L. 
  
 
 
Figure 16: Protein sequences sharing significant sequence identity with ImuA’L. The red bar marks a 
protein sequence perfectly aligned to the target – here ImuA’S. Black lines indicate sequence alignments 
of ≤ 40%. Homology modelling requires templates with sequence identities ≥ 30% for reliable model 
building. The crystal structure of RecA with a sequence identity of 37% would appear to represent a good 
starting point to model ImuA’L. A sequence coverage of only 23%, however, indicates that less than a 
quarter of the length of ImuA’L is covered.  
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The most critical step in homology modelling is alignment of the target to the template. An 
incorrect alignment will result in an erroneous model. To ensure a meaningful alignment of 
ImuA’L and the template RecA from M. smegmatis, ClustalW2 was used to align the two 
sequences (Figure 17). ClustalW2 uses scoring functions composed of a gap penalty function and 
a substitution score matrix to match every residue in the target sequence to those of the 
template sequence. The final score is a sum of the gap penalties and the pairwise substitution 
scores.  
 
Figure 17: Alignment of M. smegmatis RecA (PDB code: 1UBC) with ImuA’L from ClustalW2 (Larken et 
al., 2007)  
 
The aligned sequence was transferred to the SWISS-MODEL user interface. Based on this 
alignment, the SWISS-MODEL pipeline threads the backbone of the target sequence onto that of 
the template to retain not only the Cα positions, but also the phi and psi angles and the secondary 
structure elements. The alignment of secondary structure of ImuA’L and template 1UBC is shown 
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in Figure 18. A comparative modelling package then adjusts side chain conformations to minimize 
collisions, and improves the model by energy minimization and/or molecular dynamics.  
 
Figure 18: Aligned secondary structure of ImuA’L and structure 1UBC from M. smegmatis. H: α-helices, 
E: β-strands; C: loop regions; dashed lines insertions/deletions. 
 
ProMod-II of the SWISS-MODEL pipeline generates an all-atom model for the target using the 
sequence alignment by “modelling by segment matching” or “coordinate reconstruction” based 
on the observation that most protein hexapeptides cluster to around 100 structural classes. 
Models are constructed from a subset of guide template positions (conserved Cα’s) connected 
by short all-atom segments from known protein structures. Where loop modelling is not 
satisfactory, MODELLER is used to generate an alternative model.  
The graphics program PyMol (PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, 
LLC.) was used to graphically compare the template and target model structures (Figure 19). 
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Figure 19: Partial model for ImuA’L. A) Structural model of ImuA’L generated by SWISS-MODEL; B) The 
structural model of ImuA’L superimposed on the experimental structure of RecA from M. smegmatis (PDB 
code 1UBC).  
The ImuA’ model accounts for residues 85 to 235, roughly covering the first domain of ImuA’S or 
the central domain of ImuA’L. The N-terminal domain of ImuA’L (residues 1 to 90) and the C-
terminal domain of ImuA’S/L (235-294) are not covered.  
 
Figure 20: Three potential domains of ImuA’L. Blue: The N-terminal domain (residues 1 to 90); Orange: 
central domain (91 to 235) homologous to RecA; Red: C-terminal domain (235-294). ImuA’S maps to 
domains two and three of ImuA’L.  
 
An equivalently derived model for the N-terminal domain reveals a βαβ-motif in the first 39 
residues with high sequence identity to a stretch of E. coli pyrimidine nucleoside hydrolase 
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(Figure 21). No significant identity to any known protein could be identified for the C-terminal 
domain, preventing a reliable structure-based model being derived. 
 
Figure 21: Modelling the N-terminal domain of ImuA’L. Top: sequence alignment of the ImuA’L N-terminal 
domain with four sequences sharing βαβ motifs. Bottom: βαβ-model structure for ImuA’L N-terminal 
domain. 
 
To investigate DNA binding by ImuA’L, the crystal structure of RecA from E. coli, solved in complex 
with double stranded DNA (PDB code 3CMW) (Chen et al., 2008), was superimposed on the 
ImuA’L model structure in PyMol. Recognition of the double stranded DNA by RecA involves the 
loops L1-α and L2-α of the latter (green in figure 22). Residues involved include Glu154, Ser172 
and Arg176 in L1-α and Ile199, Met197, Lys198, Thr208, Gly200, Gly211, Gly212 and Asn213 in 
L2-α (Chen et al., 2008). The L2-α loop is absent in ImuA’L implying that ImuA’L does not bind 
DNA like RecA. The L1-α loop is present in ImuA’L but lacks the α-helical portion (residues?). The 
L1 loop of ImuA’L consists of only hydrophobic residues, which could bind DNA. If ImuA’L were 
thus to bind DNA it would do so in a manner unrelated to RecA.  
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Figure 22: ImuA’L model structure (pink) superposed on the crystal structure of the E. coli RecA/DNA 
complex (PDB code: 3CMX; brown). A): Superimposed structures showing limited physical contact 
between the ImuA’L and DNA. B): Magnified section of the L1-α and L2-α loops of RecA/DNA (green) 
known to interact with DNA. Note the absence of L2-α in ImuA’L and the significantly different 
conformation of L1-α in ImuA’L (purple) compared to RecA (green).  
 
3.6.1 Model Evaluation 
Estimating the quality of a modelled structure is essential as models more similar to the original 
crystal structure are generally more reliable for practical applications. SWISS-MODEL provides an 
estimate of the model quality based on a QMEAN potential, which compares geometrical 
features of the model such as pairwise atomic distances, torsion angles and solvent accessibility 
to statistical distributions from experimental structures. Residue scores range from 0 to 1 with 
higher scores indicating higher reliability. A global QMEAN, calculated to estimate the overall 
model quality, is provided as a Z-score relating the QMEAN to scores for X-ray structures. The 
QMEAN is combined with GMQE values from the target-template alignment to give a combined 
quality estimate for the model structure. Again, values near one indicate the most reliable model. 
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Figure 24: Model Quality Estimate for ImuA’L. Left: QMEAN estimate for each residue. Peaks are generally 
above 0.5 indicating fairly reliable residue positioning of model compared to template. Right: Overall 
estimate of model quality. The shaded region marks Z-scores of template structures. The red star indicates 
the quality of the model. A QMEAN of near 0.5 indicates that some useful information may be derived 
from the structural model of ImuA’L. The position of the red star along the X-axis indicates the overall 
model coverage compared to the template used and in this case only about 160 residues in the target are 
modelled on the template with about 600 residues hence a sequence overage of less than 26% in the 
model.  
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4 Discussion 
  General Statement of Research Outcome  
This study aimed at structurally analysing ImuA’ from Mtb. This revealed that 1) imuA’ of Mtb 
exist as two variants, imuA’S and imuA’L; 2) The amplification of imuA’ was achieved by a two-
step PCR but not by the conventional three step PCR procedure; 3) Large amounts of recombinant 
ImuA’ are produced in E. coli albeit as insoluble protein; 4) Modelling of ImuA’L indicate its middle 
domain to be homologous to M. smegmatis RecA. The un-modelled C-terminal domain is known 
to be critical for the interaction of ImuA’ with ImuB (Ndwandwe, 2013; Warner et al., 2010). 
Both ImuA’ and ImuB are critical to the functioning of DnaE2 (ImuC) (Ndwandwe, 2013; Warner 
et al., 2010), a C-family DNA damage-inducible polymerase implicated in translesion synthesis, 
virulence and the emergence of antibiotic resistance in Mtb (Boshoff et al., 2003). DnaE2 lacks a 
β-clamp binding motif. The β-clamp is functionally replaced by the pseudo-polymerase ImuB 
(Warner et al., 2010). The C-terminal loops of both ImuA’ and ImuB are critical for their roles as 
DNAE2 accessory proteins (Ndwandwe, 2013) despite the precise role of ImuA’ remaining elusive.  
 
  Analysis of the Mtb imuA’  
The Mtb imuA’ gene provides an example of uncertainties in Mtb genome annotation resulting 
from Mtb using transcription start codons other than ATG. Two start sites have been proposed 
as the origin of imuA’. The CMR JCVI database lists imuA’ genes for both start sites. One, labelled 
imuA’L in this work, starts at a GTG codon 270 bp upstream of the ATG codon of the other, here 
denoted imuA’S. The first 270 bases of imuA’L are shared by another 5’ end of another gene 
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encoded by the opposite strand. Databases such as the TBDB and TubercuList correspondingly 
only capture the imuA’S sequence. The model structure of ImuA’L generated in this study (Figure 
19) and the findings of Ndwandwe (2013) suggest that the imuA’S and imuA’L are transcribed 
under different conditions, with the N-terminal domain of ImuA’L having a unique function. 
Inserting an artificial start site 399 bp downstream of the imuA’L start codon (or 129 bp 
downstream of the imuA’S start codon) still yields a protein that binds ImuB (Ndwandwe, 2013), 
indicating that the first 133 amino acids of ImuA’L are not required for its interaction with ImuB. 
The nearest ImuA’L homologue, RecA, is structurally related to the central domain of ImuA’L or 
the first domain of ImuA’S.  
 Two-Step Amplification of imuA’ 
The high GC content of both imuA’S (70%) and imuA’L (68%) proved challenging during 
amplification in that primers had to be shorter than the recommended 18 bp to achieve melting 
temperatures between 52 and 58°C. This, however, resulted in unspecific priming as the G or C 
at the 3’-end of the primers allow rapid, non-specific annealing to the template. To restore the 
specificity, primers were designed with T or A at their 3’-end. In addition, the annealing step was 
eliminated, to prevent non-specific primer binding and amplification of truncated imuA’ due to 
different GC-contents of the 5’- and 3’-ends. With a much higher GC content at the 5’-end of the 
gene, primers had highly disparate melting temperatures potentially causing mis-annealing 
during the annealing step. Eventually the full-length gene was amplified using a two-step PCR. 
This method similarly proved successful for the amplification of imuB, imuC and carD from Mtb 
(personal communication: Jeremy Boonzaier, UWC, Simon Broadly, UCT), and would appear to 
be the method of choice to amplify genes from GC-rich genomes in general. 
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  Production of ImuA’ for Structural Studies 
Protein structural studies often fail due to difficulties in producing soluble protein or crystallizing 
a protein (Arbing et al., 2013; Christendat et al., 2000; Terwilliger et al., 2009). In this case, 
producing soluble, recombinant ImuA’ in E. coli proved an insurmountable hurdle. Invariably, 
SDS-PAGE analysis would show the protein to be produced well but to be channelled to insoluble 
inclusion bodies. This observation is consistent with in silico prediction of the solubility of 
recombinant ImuA’ in E. coli, which estimated the chances of producing soluble, recombinant 
ImuA’ in E. coli at less than 7% (Table 7). Generally, Mtb proteins are difficult to produce solubly 
in E. coli (Chim et al., 2011). The reasons may include 1) the high GC content and resulting 
secondary structures in the mRNA 5’-regions; 2) bias in codon usage between Mtb and E. coli; 
properties of protein  such as protein size, hydrophobicity and acidity; and 3) the lack of essential 
chaperones (Arbing et al., 2013; Allert et al., 2010). The GC-content of 66% in the Mtb genome 
contrasts with 51% in E. coli. However, the high GC-content alone is unlikely to be the reason for 
the insolubility of ImuA’ in E. coli as genes from other mycobacterial species with similar GC-
contents are efficiently produced as soluble proteins in E. coli (www.webtb.org/Targets).  
Differences in codon usage or codon usage bias between production host and gene source 
organism is another factor known to influence protein solubility (Angov, 2011). By altering the 
rate of mRNA translation, protein folding is affected (Fedyunin et al., 2012). Rare or slow codons 
are normally located at regions in an mRNA corresponding to protein domain boundaries or at 
transition points between structured and unstructured regions of the polypeptide (Angov, 2011; 
Saunders & Deane, 2010; Zhang et al., 2009). The associated slowing of transcription allows 
sufficient time for domain folding. Differences in host and source codon usage results in this 
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message being lost, affecting protein folding and insolubility. E. coli strains have been engineered 
to supply normally rare tRNAs (Baca & Hol, 2000; Redwan, 2006). The use of BL21-CodonPlus 
cells that provide additional tRNAs did not improve the solubility of ImuA’.  
Physicochemical properties of a protein also significantly influence its solubility. Generally, low 
molecular weight (<60 kDa), low hydrophobicity and moderately acidic proteins are likely to be 
more soluble (Slabinski et al., 2007). High pI values, by comparison, decrease solubility of proteins 
in E. coli (Mehlin et al., 2006). The poor solubility of ImuA’ in E. coli may be caused by a 
combination of these properties. With molecular weights of 20.8 kDa and 29.9 kDa for ImuA’S 
and ImuA’L, both proteins are within the range for production in E. coli. However, both are highly 
hydrophobic and have pI-values of 10.7 and 11.2, resulting in misfolding and protein insolubility.  
The solubility of protein may further be affected by the conditions of induction. The vectors into 
which imuA’ was cloned had a lac promoter, which induce gene expression when lactose is 
present. Here, the lactose metabolite analogue isopropyl β-D-1-thiogalactopyranoside (IPTG) 
was used to induce gene expression. Varying induction conditions including IPTG concentrations, 
induction temperatures and induction time were explored for soluble production of ImuA’. 
However, varying these variables independently and in combination did not improve the protein 
solubility.  
Insoluble proteins are mostly channelled to inclusion bodies (Williams et al., 1982). However, a 
significant proportion of proteins may initially be produced in a soluble form only to aggregate 
after cell lysis (Leibly et al., 2012). Subjected to the optimal lysis buffers, they may remain in 
solution. Conditions required include an ideal pH, ionic strength or various additives. Here, 
buffers with a range of pH values were tested for ImuA’ solubilisation, however, ultimately 
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without success (Figure 12). The insolubility of ImuA’ therefore does not appear to be linked to 
aggregation of soluble protein. 
Proteins in inclusion bodies do not adopt a native fold but can be often be solubilised, purified 
and refolded to their native conformations (Vallejo & Rinas, 2004). Inclusion body proteins are 
further protected from by cellular proteases and contain target proteins in high concentration 
with little cellular material. Large quantities of fairly pure protein can therefore often be isolated 
from inclusion bodies (Li et al., 2004; Singh & Panda, 2005). In this study, significant quantities of 
inclusion bodies were isolated, washed and solubilised in 8 M urea. However, refolding of 
solubilised protein was not successful. Inter alia, the urea concentration was gradually lowered 
by dialyzing against buffers with successively lower urea concentrations, to allow for protein to 
slowly fold back to a native conformation. However, protein precipitated as the urea 
concentration reached about 2 M indicating that folding did not succeed. In “on-column” 
refolding, the urea concentration was gradually lowered to 3 M after immobilising the protein on 
Ni-NTA resin – again to allow for slow refolding. However, eluting with 3 M urea buffer and 
increasing imidazole concentrations did not dislodge the protein from the resin even after 
overnight incubation (Figure 14) implying non-specific binding to the column due to improper 
folding. These outcomes confirm that “refolding is an empirical process, which needs to be 
optimized in each individual case to achieve reasonable yields of the protein in its functional 
form” (Tsumoto et al., 2003). Optimal conditions have so far eluded us.  
Yet a further strategy to produce soluble protein is to produce proteins together with their 
physiological partners. A colleague failed in an attempt to co-produce ImuB and ImuA’ using the 
pETDuet system (Novagen) (Ndwandwe, 2013). Therefore, co-transformation of imuA’ in the 
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pCOLD I vector (ampicillin resistance), and imuB in pETM-30 (kanamycin resistance) and co-
expression in E. coli BL21 (DE3) cells was attempted in this study. Production of both proteins 
improved and an estimated 50% ImuA’ was seen to be soluble. However, the resulting ImuA’ 
protein failed to bind to Ni-NTA resin preventing its purification (Figure14). Clearly, however, the 
solubility of ImuA’ appears to depend on ImuB being present, indicating that various routes of 
co-expression may need further refinement. 
 Insights from the model structure of ImuA’L 
Sequence analysis of ImuA’L revealed the protein to consist of three domains: 1) An N-terminal 
domain, unique to ImuA’L, containing a βαβ-motif similar to that of pyrimidine nucleoside 
hydrolysing enzymes; 2) a central domain related to the N-terminal domain of M. smegmatis 
RecA; and 3) a C-terminal domain of unknown fold. Despite homology to RecA, the central 
domain lacks critical loops for DNA binding loosing most contacts observed between E. coli RecA 
and DNA. A possible exception is a C-terminal stretch of hydrophobic amino acids which could 
indicate some residual DNA binding (Figure 22). Possibly ImuA’L does not bind DNA itself but 
interacts with DNA-binding proteins such as ImuB during translesion synthesis. The C-terminal 
domain of ImuA’L is predicted to be highly disordered on its own but is critical for the interaction 
with ImuB (Ndwandwe, 2013). The details of this interaction, however, remain to be unravelled.  
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5 Conclusion and Outlook 
The structural characterization of Mtb ImuA’ has been carried out in this work. The genes were 
successfully amplified by two-step PCR, cloned and expressed in E. coli. The proteins were 
produced in large quantities in E. coli though were invariably channelled to inclusion bodies. 
Attempts to refold the protein similarly proved unsuccessful. Instead, structural information for 
ImuA’ was derived from homology modelling. The structural model revealed the central domain 
of ImuA’ to be related to N-terminal domain of RecA despite lacking some loop regions necessary 
for DNA binding. The C-terminus of ImuA’ is disordered but binds ImuB by an unresolved 
mechanism. 
Future studies on this critical complex should presumably focus on co-producing ImuA’, ImuB and 
ImuC (DnaE2) plus any other subunits of this complex to reveal the exact stoichiometry of the 
subunits as well as their three-dimensional arrangement, to establish how the complex is able to 
restore DNA translesion.  
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Part II 
 
 
Structural Analysis of a Gh9 C1 Cellulase from a Metagenomic Library 
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1. Introduction  
1.1.  Biofuels: Better Alternatives to Fossil Fuels  
Cellulases are enzymes that catalyse the hydrolysis of cellulose. Cellulases are important in 
modern industry and hold great potential in biofuel production (Yan & Wu, 2013). The rapid 
depletion of fossil fuel deposits and the deteriorating impact of fossil fuel combustion on the 
environment necessitate the exploration of cleaner and renewable energy sources such as 
biofuels. Countries such as Brazil and the United States of America have made significant progress 
in producing and consuming biofuels. Overall, though, biofuels account for less than 10% of total 
world fuel usage (IEA, 2013).  
Biofuels are energy sources derived from organic materials i.e. plant materials or animal waste. 
Biofuels are classified as first, second or third generation. First generation biofuels derive from 
food crops such as grains, sugar beet, oil seeds and sugar cane (Lee & Lavoie, 2013). The use of 
food crops for fuel production raises questions about food security in what is referred to as the 
‘food/fuel problem’ (Tenenbaum, 2008). Attention has therefore shifted to biomass such as 
agricultural and forest residues for second generation biofuel production (Sims et al., 2008). This 
biomass is rich in lignocellulose, the most abundant biomaterial on earth by mass, and constitutes 
an alternative to both first generation biofuels and fossil deposits (Sánchez & Cardona, 2008). 
Currently, however, cost-effective technologies to convert biomass to second generation biofuels 
on an industrial scale are lacking mainly due to the recalcitrance of lignocellulose to degradation 
(Xia et al., 2013).  
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1.2. Analysis of the Components of Lignocellulose 
Lignocellulose from plant cell walls consists of the components cellulose, hemicellulose and 
lignin. Cellulose, the most abundant constituent, is a β-(1–4)-linked polymer of glucose arranged 
in layers held together by hydrogen bonds. Two forms of cellulose, crystalline and amorphous 
cellulose often occur together in a 3:1 ratio respectively (Somerville et al., 2004; Quiroz-
Castañeda & Folch-Mallol, 2013). 
Hemicellulose is the second most abundant component of lignocellulose. It is made up of 
different pentose and hexose sugars such as arabinose, galactose, glucose, mannose and xylose 
linked β-(1–4) to create a polysaccharide chain (Scheller & Ulvskov, 2010). The hemicellulose 
chain forms hydrogen bonds with cellulose microfibrils driving the overall assembly of cell wall 
structure. Counterintuitively, the hydrogen bonds cross-linking hemicellulose and cellulose 
prevent cellulose aggregation and mechanically weaken the cell walls to allow for cell wall 
expansion (Somerville et al., 2004).  
Lignin, the third constituent of lignocellulose, consists of three phenolic components, namely p-
coumaryl (H), coniferyl (G) and sinapyl alcohols (S) that polymerize in different ratios in plants, 
wood tissue and cell wall layers. Lignin controls cell wall porosity, adhesion of adjoining cells and 
the ionic environment of the cell wall (Somerville et al., 2004; Wi et al., 2005).  
Cellulose, hemicellulose and lignin come together into micro and macro-fibrils as depicted on 
figure 25 below (Rubin, 2008). 
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Figure 25: Structural depiction of the composition of lignocellulose - the most abundant biomass on 
earth. Image obtained with permission, from EM Rubin (2008).  
 
1.3. Glycoside Hydrolase for Cellulose Degradation  
Lignocellulose degradation is a bottleneck for large-scale, industrial production of biofuels. 
Cellulolytic enzymes could overcome this hurdle (Wang et al., 2009). Three cellulase types that 
synergistically convert cellulose to glucose are endoglucanases (EC 3.2.1.4), exoglucanases 
(EC3.2.1.91) and β-glucosidases (EC3.2.1.21) (Lynd et al. 2002).  
Glucose is easily fermented to useful chemicals. However, hydrolysis of cellulose to glucose by 
cellulases is inefficient, making biofuels from lignocellulosic biomass uneconomical (Duan et al., 
2009). Understanding the biology of cellulases may be critical in overcoming this bottleneck in 
biofuel production. 
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Cellulases are glycoside hydrolases that hydrolyse β-(1–4)-glycosidic linkages of cellulose 
(Sandgren, 2003). Glycoside hydrolase (GH) enzymes are found in all domains of life but differ in 
enzymatic activity with marginal changes in primary structure significantly affecting substrate 
specificity. GHs have different domain structures with each domain having a unique evolutionary 
history (Naumoff, 2011). 
Interest in glycoside hydrolases started during the first oil crisis as cellulose in plant biomass was 
recognized as a potential source of energy. The biotechnological application of GHs may remedy 
the current environmental crisis ensuring they remain a focus of research (Sulzenbacher et al., 
1996; Xia et al., 2013).  
1.3.1. Classification of Glycoside Hydrolases  
 
GH enzymes are classified according to their sequences and structures. Currently the 
“Carbohydrate Active Enzyme” (CAZY) database recognizes 133 GH families. Family members 
share catalytic machinery, molecular mechanism and/or glycosidic bond geometry (Gebler et al., 
1992; Henrissat & Davies, 2000). 
Mechanistically GH enzymes are “retaining” or “inverting” depending on the configuration of the 
anomeric oxygen before and after the reaction (Koshland, 1953). Retaining GHs use a general 
acid/base and a nucleophile during catalysis while inverting GHs require a catalytic acid and a 
catalytic base for catalysis (Vuong & Wilson, 2010). Variations from retaining and inverting 
mechanisms occur in some GH families, though members of one GH family mostly share a 
mechanism of action. Family GH97 is a notable exception in accommodating both retaining and 
inverting GH enzymes (Gloster et al., 2008). Families GH4 and GH109 utilize the cofactor NAD in 
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glycosidic bond hydrolysis and cleave both α- and β-glycosidic bonds (Chakladar et al., 2014; Yip 
et al., 2004). 
GH families are grouped into overarching ‘clans’. Each clan comprises families with similar 
tertiary structure, catalytic residues and enzymatic mechanism. Clan members potentially derive 
from a common ancestor (Henrissat et al., 1996). 
Table 8: Cellulase Families and Clans 
Clan  Common fold Families within clan 
GH-A (β/α)8 1 2 5 10 17 26 30 35 39 42 50 
51 53 59 72 79 86 113 128 
GH-B β-jelly roll 7   16 
GH-C β-jelly roll 11 12 
GH-D (β/α)8 27 31 36 
GH-E 6-fold β-propeller 33 34 83 93 
GH-F 5-fold β-propeller 43 62 
GH-G (α/α)6 37 63 
GH-H (β/α)8 13 70 77 
GH-I α+β 24 46 80 
GH-J 5-fold β-propeller 32 68 
GH-K (β/α)8 18 20 85 
GH-L (α/α)6 18 20 85 
GH-M (α/α)6 8 48 
GH-N β-helix 28 49 
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1.3.2. Glycoside Family 9 (GH9) Enzymes 
The much studied GH9 family mainly includes cellulases such as endoglucanases, 
cellobiohydrolases, β-glucosidases and exo-β-glucosaminidase (Guérin et al., 2002). GH9 
enzymes use an inverting catalytic mechanism and are mechanistically distinct from all other GH 
families precluding their assignment to any clan. Structurally they share an (α/α)6 fold with 
aspartate and glutamate residues acting as catalytic nucleophile/base and catalytic proton donor 
respectively (Sakon et al., 1997). Around 1620 GH9 enzyme-encoding genes have been identified 
in all domains of life with 844 eukaryotic, 561 bacterial, four archaeal and 211 unclassified genes. 
Eleven crystal structures of proteins from this family have been determined - ten bacterial and 
one eukaryotic (http://www.cazy.org/GH9.html).   
1.4. Metagenomic Potential for Cellulose Deconstructing Enzymes 
Despite much research into prokaryotic cellulases, efficient degradation of cellulose has not been 
achieved. Metagenomics, which involves the direct analysis of DNA fragments from 
environmental samples for novel genes and gene products, may yet yield better cellulose 
deconstructing enzymes for an industrial application (Xia et al., 2013). Despite countless attempts 
to isolate and characterize cellulases from uncultured microbial communities, the full 
biotechnological potential of environmental cellulases remains to be realized (Ferrer et al., 2005; 
Healy et al., 1995; Kim et al., 2008).  
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1.5. The GH9 C1 Cellulase 
This study is geared towards the analysis of the structure of a GH9 cellulase from an uncultured 
environmental sample. The enzyme named GH9 C1 cellulase was isolated from straw based 
mushroom compost from Medallion mushroom farm, Stellenbosch, South Africa. Samples were 
collected over two periods and a library constructed from fresh and frozen compost. The 
metagenomic libraries were screened and putative gene cloned into protein expression vectors 
(personal communication Stephen Mackay, University of the Western Cape).  
The GH9 C1 cellulase gene was cloned and expressed from a pET21a vector. Using 
chromatographic methods, the protein was purified and characterized. The protein showed 
maximum activity between pH 5.5 and 7.0 and a temperature optimum between 50 and 55oC. 
GH9 C1 cellulase has a low thermostability and loses activity at low temperatures.  It has a high 
specific enzyme activity (personal communication Stephen Mackay). Low thermostability 
coupled to high enzyme activity and specificity may imply a fast turnover rate and rapid 
production in natural environments.  
The aim of this project is to structurally analyse this novel GH9 C1 cellulase. The protein was to 
be produced, purified, crystallized and its crystal structure determined. 
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2. Materials and Methods  
A recombinant plasmid containing a gene encoding GH9 C1 cellulase cloned by Stephen Mackay 
(Institute of Microbial Biotechnology and Metagenomics, IMBM, University of the Western Cape) 
was provided for this study. The vector was constructed as shown in Figure 26. 
 
Figure 26: pET21a_gh9_c1 is a pET21a based expression vector with a His6-tag encoding sequence at the 
C-terminus of the gene encoding Gh9_C1 (blue). The gene is cloned between a 5’-NdeI and 3’-XhoI 
restriction enzyme sites. The plasmid contains an ampicillin resistance gene (Amp+) for antibiotic 
selection.  
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2.1. Protein Production and Purification  
2.1.1. Starter Culture  
A starter culture was prepared by inoculating 50 mL LB medium (100 μg/mL ampicillin) with 
pET21a_C1-SP transformed E. coli BL21 (DE3) and incubating at 37oC and 170 rpm shaking 
overnight.  
2.1.2. Main Culture 
The starter culture was used to inoculate 1 L of LB medium (100 μg/mL ampicillin) in a 5 L culture 
flask. The flask, capped with aluminium foil, was incubated at 37°C with shaking at 170 rpm until 
the OD600 was between 0.6-0.8. The culture was induced for recombinant gene expression with 
1 mM isopropyl-D-thiogalactopyranoside (IPTG) and further incubated overnight as before but at 
30oC.   
2.1.3. Cell Harvesting and Sonication 
The final culture was transferred to two 500 mL centrifugation tubes and centrifuged at 11 000 x g 
and 4oC for 15 min. The supernatant was decanted from the cell pellet and the latter resuspended 
in chilled lysis buffer with 1 mM serine protease inhibitor PMSF. The cells were ruptured on ice 
by sonication at amplitude 28 by six cycles of 30 s sonication and 30 s resting time to prevent 
protein heat denaturation. 0.4 ug/mL DNAse was added to the ruptured cells, incubated on ice 
for 20 min and centrifuged at 16 000 x g and 4°C for 1 h to separate soluble from insoluble cellular 
components. 
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2.2. Protein Purification 
2.2.1. Nickel–nitrilotriacetic Acid (Ni+2–NTA) Affinity Chromatography 
The GH9 C1 cellulase construct (Figure 26) was C-terminally His6-tagged to assist purification of 
recombinant protein by immobilized metal-affinity chromatography (IMAC). Histidine readily 
binds to immobilized metal ions through its imidazole ring (Bornhorst & Falke, 2000).  
Two millilitres of Ni+2-NTA were washed with 5 column volumes (CV) of water, equilibrated with 
5 CV of lysis buffer and mixed with the soluble cellular component (see above). The mixture was 
agitated on a roller mixer overnight at 4°C and transferred to a gravity flow purification column. 
Unbound proteins were collected as the flow through. The matrix was washed with 5 CV of lysis 
buffer collected as wash fractions. Further washing followed with 2 CV each of 5, 10, 25, 50 and 
100 mM imidazole enhanced lysis buffer. All remaining proteins were finally eluted with 250 mM 
imidazole. Samples were analysed by SDS PAGE (sections 2.3.5- 2.3.7). 
2.2.2. Anion Exchange Chromatography 
Fractions identified by SDS PAGE to contain GH9 C1 cellulase were pooled, sterile filtered using a 
0.2 µm filter and further purified by anion exchange Hi-trap QHP chelating column (GE 
Healthcare). The column was equilibrated with 10 CV of buffer A (25 mM Tris-HCl pH 8.5 and 
50 mM NaCl), rinsed with 1 CV of buffer B (25 mM Tris-HCl pH 8.5 and 1 M NaCl) to ensure all 
anion binding sites are occupied by Cl- and followed by protein loading. The column was washed 
with buffer A until all unbound protein had eluted (OD280 returned to baseline). Proteins 
 
 
 
 
77 
 
remaining bound to the column were eluted with a linear gradient (0-100%) of buffer B. Fractions 
within peaks of the chromatogram were analysed by SDS PAGE for protein. 
2.2.3. Size-exclusion Chromatography 
Samples from the anion exchange peak and confirmed by SDS PAGE to contain protein were 
pooled and concentrated to a final volume of 1 mL. The concentrated sample was injected onto 
a Superdex 200 16/60 column (GE Healthcare) with running buffer (25 mM Tris-HCl pH 8.5, 
50 mM NaCl) and a flow rate of 1 mL/min. The elution profile was evaluated using the absorbance 
at 280 nm. 
2.2.4. Protein Concentration 
GH9 C1 cellulase fractions corresponding to the chromatographic peak and analysed by SDS-
PAGE were pooled and concentrated by ultracentrifugation using a Vivaspin-6 concentrator 
(Sartorius, Germany) with a MWCO of 30 kDa. The absorption at 280 nm (A280) was measured at 
intervals of centrifugation and the process terminated once the required concentration was 
achieved. To exchange the buffer or reduce the salt concentration, the concentrated protein was 
diluted with suitable buffer and re-concentrated to the desired volume.  
2.2.5. Protein Quantification 
Aromatic amino acids absorb UV light at a wavelength of 280 nm. The protein concentration of 
GH9 C1 cellulose was determining by measuring the A280 on a Nandrop ND-1000 spectrophoto-
meter (PeqLab, Germany). For concentrated protein samples, the flow through of the 
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concentrator was used as a blank solution. The molar extinction coefficient ε280 was calculated 
from the amino acid composition. According to the Beer-Lambert equation 
   C = A280 / ε. D     Equation 1 
the concentration C may be calculated if the values A, D , ε are known. The thickness of the 
measuring chamber D is mechanically adjusted by the Nanodrop spectrophotometer. This 
method does not distinguish individual proteins in a mixture. Hence the concentration of a 
protein is only accurate if contaminants are negligible.  
2.2.6. Sample Preparation for Crystallization 
The protein was concentrated to 10 mg/mL in a buffer containing 50 mM NaCl and 25 mM Tris-
HCl pH 8.0. The concentrated sample was filtered using either a 13 mm syringe filter with a pore 
size of 0.20 µm or a micro-centrifuge tube with a molecular weight cut off of 10 kDa. The 
concentrated and filtered samples were stored at 4oC for crystallization screening. 
2.3. Protein Crystallization Screen  
Crystallization experiments were performed by sitting-drop vapour-diffusion method in 96-well 
crystallization plates (Hampton Research) using the Mosquito HTS (TTP Labtech, U.K.) dispensing 
robot. Commercial crystallization screens were used providing a range of precipitant, salt, buffer 
and pH formulations. Screens used include JCSG CORE I, II, III, IV and CORE+ suites, AmSO4, MPD, 
PACT, PEGs and PEGs II Suites (Qiagen) and Crystal Screen, Crystal Screen II and Crystal Screen 
Lite (Hampton Research Corp). Crystallization drops consisted of 300 nL protein solution with 
150 nL reservoir solution equilibrated against 80 μL of reservoir solution at 18°C. 
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Conditions producing lead crystal were manually optimized by varying the physicochemical 
parameters such as precipitant and protein concentrations, ionic strength and temperature on 
hanging drop vapour-diffusion 24-well crystallization plates (Hampton Research). Further 
optimization was attempted using 1) Additive Screen (Hampton Research, USA), 2) by micro, 
cross and streak seeding, 3) by varying the ratio of protein: reservoir volumes, and 3) by adding 
0.5-3% glycerol.  
2.3.1. Data collection and Evaluation 
Single crystals were harvested from their mother liquor, rapidly transferred to cryoprotectant 
solution (mother liquor supplemented with 20-30% glycerol or 20-30% PEG 400) and flash-cooled 
either in liquid nitrogen or by mounting them in a liquid nitrogen stream at 100 K.  
A home-source, rotating-anode X-ray generator (MicroMax-007HF, Rigaku, Japan) was ramped 
to an input current of 30 mA and a voltage of 40 mV resulting in a vacuum ion gauge value of 
130-160. Diffraction data was collected using Cu-Kα radiation (λ = 1.54 Å) using a Saturn 944HG 
CCD detector (Rigaku, Japan). The crystals were X-irradiated for 10 s and two test images 90° 
apart collected. Denzo and Scalepack of the HKL3000 suite (Minor et al., 2006; Otwinowski & 
Minor, 1997) were used for data evaluation and scaling.  
2.4. Modelling the Three-Dimensional Structure of GH9 C1 Cellulase 
Comparative or homology modelling of GH9 C1 cellulase involved four steps: 1) template 
identification, 2) template-target alignment, 3) model building and 4) model quality evaluation. 
A BLASTp search of the protein databank (PDB) using the amino acid sequence of GH9 C1 cellulase 
returned homologues of experimentally determined crystal structures. On the basis of a 
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sequence coverage of 96%, an E-value of 1x10-84, and a sequence identity of 32%, the crystal 
structure of the cellobiohydrolase (CbhA) from Clostridium thermocellum (PDB ID: 1UT9) was 
chosen as the template to model GH9 C1 cellulase. The target and template amino acid 
sequences were aligned using ClustalW2 and submitted to the user interface of SWISS-MODEL 
running under alignment mode. The SWISS-MODEL pipeline uses the program ProModII to thread 
the target sequence onto the coordinates of the template structure. The model quality is fine-
tuned using Gromos96, an energy minimization program. The output models were viewed and 
analysed using the molecular graphics program PyMol. 
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3. Results and Discussion 
Three-dimensional structures of proteins contain valuable information about their function and, 
potentially, their evolutionary origins. This information can be gathered through structural 
techniques such as NMR and X-ray crystallography, which require extensive preparation ranging 
from protein production and purification as well as crystallization for X-ray crystallography. 
Generally, the protein purification strategy has to be rigorously optimised to yield a sample of 
highly homogenous and concentrated protein for crystallization. In this study, GH9 C1 cellulase, 
a 63 kDa protein obtained from a compost metagenomic library, was produced as recombinant 
protein in E. coli, extracted and purified by immobilized metal-affinity, ion exchange and size 
exclusion chromatography. The protein was crystallized and the crystals X-rayed for diffraction 
data. The resolution of the diffraction data was, however, too weak for use in structure 
determination by molecular replacement. The structure of GH9 C1 cellulase was therefore 
obtained by homology modelling and presented using the molecular graphics program PyMol.  
3.1. Production and Purification of GH9 C1 Cellulase 
The GH9 C1 cellulase was easily induced and overproduced as a His6-tagged protein in E. coli BL21 
DE3 cells. The protein was recovered in the soluble fraction with minimal protein lost in the 
insoluble fraction. Induction conditions with increasing IPTG concentrations at 30°C did not 
increase protein yield. GH9 C1 cellulase co-purified with a minor protein impurity running just 
below the major protein band. This contamination remained even after His6-tag purification. 
Initially this band was suspected to be nickel-binding Hsp60 from E. coli produced under stress 
conditions. Alternatively it could represent a degradation product of the target protein. 
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Purification using protease inhibitor PMSF, protein production in a protease-free strain (Rosetta 
2), and cold induction did not prevent the co-purification of the minor product, already visible in 
the crude extract. Ion exchange chromatography and size exclusion chromatography similarly did 
not remove the co-purified protein. Zymogram and Western blot analysis of the co-purified 
protein indicated cellulase cleaving activity and the presence of a His6-tag (personal 
communication Stephen Mckay, IMBM, UWC). The co-purified protein is thus most likely to be 
an N-terminal degradation product of the target protein, retaining its enzymatic activity and its 
His6-tag. Figure 27 represents a summary of the purification of GH9 C1 cellulase by Ni+2-NTA 
affinity chromatography where the lower band constitutes the N-terminal degradation product.  
 
 
 
 
Figure 27: Ni+2-NTA affinity purification of GH9 C1 cellulase. Lane 1: Soluble cellular component; Lane 2: Ni+2-
NTA resin before loading sample; Lane 3: Flow through after overnight agitation of sample on resin; Lane 4: 
Resin and protein sample; Lane 5-10: Wash fractions with increasing imidazole concentrations as follows: 0, 
5, 10, 25, 50 mM and 75 mM respectively: Lane 11 and 12: Elution fractions with 100 and 250 mM imidazole 
respectively; Lane M: PageRuler Prestained Protein Ladder (Thermo Scientific) with sizes on the left in kDa. 
Lane BA: Resin sample after elution with 250 Mm imidazole. Red rectangle indicate the GH9 C1 cellulase and 
the yellow arrow indicate the N-terminally degrading band of GH9 C1 cellulase. 
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GH9 C1 cellulose eluted from the Ni-NTA beads even before imidazole was present in the wash 
buffer (lane 5). By step 5 with 50 mM imidazole all protein had effectively been eluted from the 
beads indicating that His6-GH9 C1 cellulase has a low affinity for Ni+2-NTA matrix. The low 
imidazole concentration in the pooled fractions 6-9 was easily removed by dialysis. The sample 
was concentrated to a final volume of 30 mL before loading on a Q HP column. 
3.1.1. Anion Exchange Chromatography (AEX) 
 
The partially purified GH9 C1 cellulase from affinity chromatography (Lanes 6-9, Figure 27) was 
dialyzed to remove imidazole, concentrated to 30 mL and further purified by AEX. The theoretical 
isoelectric point (pI) of GH9 C1 cellulase was calculated to be 4.6 using the ExPASy web-based 
server (Gasteiger et al., 2005). As the pI represents the pH at which the protein has a net neutral 
electric charge, it will have a net negative charge for any pH above the pI and positive below. In 
AEX, the matrix will retain negatively charged molecules whereas cation exchange 
chromatography (CEX) binds positively charged molecules. The AEX chromatogram for GH9 C1 
cellulose on an ÄKTA chromatography system (section 2.2.2) is shown in figure 28. 
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Figure 28: GH9 C1 cellulase AEX chromatogram illustrates a steadily increasing NaCl gradient (theoretical: 
green, actual: black line) in Tris-HCl pH 8.5. The peaks in the chromatogram are caused by eluting proteins. 
SDS PAGE analysis indicates proteins in peaks A and B to have the same size, which corresponds to the 
molecular mass of GH9 C1 cellulase. Fractions corresponding to Peak C did not reveal any proteinaceous 
bands in SDS PAGE indicating that it is likely to be due to remaining imidazole. Peak heights are in mAu. 
The chromatogram was produced with PrimeView program (GE Healthcare).  
 
SDS-PAGE indicates that the proteins eluting as peak A and B have the same molecular weight. 
Both peaks A and B are due to GH9 C1 cellulase but with distinct overall charges. In fact, 
additional, smaller peaks prior to A indicate that the protein has a number of ionization states at 
pH 8.5 (protonation states of histidine). Peak C eluting at a high salt concentration (90% buffer 
B) and absorbing strongly is presumably due to imidazole as SDS-PAGE did not reveal any protein 
component associated with to this peak. Fractions of peaks A and B were separately pooled and 
concentrated to final volumes of 0.5 mL using an Amicon Concentrator (Millipore). 
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Simultaneously the high salt buffer from the elution was replaced by a low salt buffer: 25 mM 
Tris-HCl pH 8.5 and 50 mM NaCl.  
3.1.2. Size Exclusion Chromatography (SEC) 
 
Protein crystallization requires that the protein be as pure and homogenous as possible and SEC 
served as a final polishing step in the purification process. As SEC separates proteins by size, 
different oligomeric forms that could interfere with crystallization will be identified and 
separated. A S200 16/60 (GE Healthcare) column was used for SEC as outlined in section 2.2.3. 
Figure 29 shows the results for peaks A and B of figure 28 respectively. Interestingly, the sample 
from peak A of figure 28 results in two peaks on SEC indicating it to be a mixture of two molecular 
entities (Figure 29 peak A1). However, no protein band is associated with (A1) while the elution 
volume of peak A2 corresponds to the major peak in Figure 29B and SDS PAGE identifies proteins 
to be similar in size to the C1 cellulase. The single symmetrical peaks in 29A and B indicates the 
protein to be homogenous, a prerequisite for crystallization. Note that a small peak 
corresponding to peak A1 is also visible in figure 29B. 
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Figure 29: SEC purification of the fractions collected from AEC peaks A and B in figure 28. A): SEC 
chromatogram of AEC peak A. Two distinct peaks eluted revealing two entities binding with similar 
affinities to the anion exchange column. Peak A1 eluted in the void volume and did not reveal any protein 
band on SDS-PAGE gel. The second peak (A2) corresponds to the elution profile in B and SDS PAGE reveals 
both to be at same MW as GH9 C1 cellulase. B): SEC chromatogram of AEC peak B. The elution profile 
corresponds to GH9 C1 cellulase - as confirmed by SDS-PAGE. Lanes 1 and 2 contain the PageRuler 
Prestained Protein Ladder (Thermo Scientific) and the partly purified GH9 C1 cellulase as a control, 
respectively. 
3.2. Protein Crystallization 
Analysis of proteins by X-ray crystallography requires the target protein be crystallized. In this 
study, both sitting drop and hanging-drop vapour diffusion techniques were used to drive the 
equilibrium of protein-containing drops towards crystal formation. Fractions under the peaks in 
Figure 29B and A2 were separately pooled, concentrated to 10 mg/mL and 16 mg/mL respectively 
in 25 mM Tris-HCl pH 8.0 and 50 mM NaCl, and stored at 4°C for crystallization. 
Initial crystal screening was conducted with commercial crystallization screens (Section 2.3) and 
crystal hits were manually optimized with varying buffer component and concentrations for 
diffraction size crystals. 
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3.2.1. Initial Screening 
The commercial crystallization screens used for initial screening provided over 750 different 
buffer conditions for crystallization. Crystals were identified in wells 6, 15, 18, 28 and 41 of the 
Crystal Screen HT (Hampton Research); conditions 61-67, 74 and 77 of PACT Suite (Qiagen); and 
conditions 6, 18 and 41of Crystal Screen Lite (Hampton Research). These conditions generally 
shared a similar precipitant (15-30% w/v polyethylene glycol [PEG] 3350 or 4000), similar salt 
concentrations (200 mM) and a neutral pH (6.5 to 8.5). These conditions were manually adjusted 
to optimize crystal morphology and diffraction. 
3.2.2. Optimization of Crystallization 
The aim of optimizing a particular crystallization condition is to increase the crystal size, to ensure 
growth of single crystals, to improve the crystals morphology, and to extend the resolution of 
diffraction. Crystals of GH9 C1 cellulase generally occurred as thin, intergrown plates. 
Optimization successfully increased the crystal size, though most crystals were still intergrown, 
indicating growth from a common crystallization nucleus. Crystals appeared within two weeks 
and increased to larger size and thickness within 24 hours.  
Optimization of the lead crystals from the PACT Suite revealed them to be salt crystals. Crystals 
from Crystal Screen HT (Hampton Research) could not be reproduced except condition 6: 30% 
(w/v) PEG 4000, 0.1 M Tris-HCl pH 8.5, 0.2 M MgCl. Conditions 6 from Crystal Screen HT and 
Crystal Screen Lite (Hampton Research) differ only in PEG 4000 concentration with the reduced 
concentration (15% w/v) improving both crystal morphology and size. 
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Figure 30: Selected crystallization hits from the PACT suite. F4: 0.1 M Bis-tris propane pH 6.5, 20% (w/v) 
PEG 3350, 0.2 M KSCN; F5: 0.1 M Bis-tris propane pH 6.5, 20% (w/v) PEG 3350, 0.2 M NaNO3; F7: 0.1 M 
Bis-tris  propane pH 6.5, 20% (w/v) PEG 3350, 0.2 M Sodium acetate; G2: 0.1 M Bis-tris  propane pH 7.5, 
20% (w/v) PEG 3350, 0.2 M NaBr; G5: 0.1 M Bis-tris  propane pH 7.5, 20% (w/v) PEG 3350, 0.2 M NaNO3. 
 
Optimized crystals from Figure 30 observed with a light polarizing microscope showed high 
birefringence, suggesting that the crystals are potentially salt crystal. None of the crystals 
absorbed bromophenol blue confirming that the crystals are highly constituted of salts, rather 
than protein. 
For Crystal Screen and Crystal Screen Lite Suites, crystals were grown from a protein to reservoir 
mixture of 2:1. Optimization of nucleation using micro-, streak- and macro-seeding resulted in 
the crystals shown in Figure 31 and 32). 
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 Figure 31: Crystal hits and optimized crystal with the Hampton Crystal Screen reagent.  
 
 
Figure 32:  Results of macro-, micro- and streak-seeding using lead condition 6 of the Hampton Crystal 
Screen Lite.  
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Figure 33 below demonstrates an interesting observation after a crystallization plate had been 
left standing in the laboratory at 20°C. After five months, crystals were observed in condition 17 
(Crystal Screen Suite). This condition (0.1 M Tris-HCl pH 8.5, 30% w/v PEG 4000, 0.2 M Li2SO4) 
differed only in its salt content (Li2SO4) from condition 6 for which crystals had previously been 
observed (Figure 31 and 32). This indicated monovalent cations to be critical for crystallization 
leading to further optimization using LiCl, NaCl and KCl. Crystals of similar morphology and size 
were obtained and used for diffraction experiments. 
 
Figure 33: Crystal observed in a plate 5 months after setup. The three images are different portions of 
the same drop.  
 
3.2.3.  Diffraction Experiments 
Nylon cryo-loops were used to transfer single crystals from the crystallization drops shown in 
figures 31, 32 and 33 to a cryo-protectant created by mixing mother liquor with 20-30% (v/v) 
glycerol or PEG 400. A cryo-protectant allows crystals to be flash cooled and maintained at 100 K 
throughout the diffraction experiment to prevent diffusion of free radicals and hence radiation 
damage. Cryo-protected crystals were flashed cooled in liquid nitrogen and mounted at the point 
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of intersection of a nitrogen stream at 100 K and the path of an X-rays beam on a diffractometer 
as described in section 2.3.1. The crystals diffracted X-rays to a moderately low resolution of 4 Å 
while reflections were quite weak and diffuse (Figure 34). Indexing of diffraction images using 
HKL3000 identified the most likely Bravais lattice as primitive monoclinic. The identified space 
group was P2 with unit cell dimensions a = 74 Å, b = 109 Å, c = 84 Å and β = -114° while α = γ = 90°. 
Due to high crystal mosaicity of >2°, the integrated dataset contained few fully recorded 
reflections. These images could not be reliably scaled nor reflections merged. As a result, 
statistics for data completeness and other parameter required to assess the data quality could 
not be determined. As a stop-gap measure, homology modelling was used to obtain structural 
information for GH9 C1 cellulase.  
 
Figure 34: Diffraction pattern for GH9 C1 cellulase crystals. Limit of resolution is ~4 Å.  
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3.3. Homology Modelling of GH9 C1 Cellulase Structure 
Modelling of protein structures provides an alternative route to obtaining three-dimensional 
structure information when experimental structures are not available. Homology or comparative 
modelling, the most reliable of these techniques, generates a model structure for a target protein 
based on the atomic coordinates of a template molecule sharing a sequence identity equal or 
larger than 30% to the target. In this project, a BLASTp search of the Protein Data Bank (PDB) 
identified cellobiohydrolase CbhA from Clostridium thermocellum as the most closely related 
protein (32% sequence identity) to GH9 C1 cellulase. Its crystal structure, PDB ID 1UT9, was thus 
used to construct a structural model for GH9 C1 cellulase. The amino acid sequences of GH9 C1 
cellulase and CbhA were aligned using ClustalW2 and the alignment provided to SWISS-MODEL 
pipe line to generate a GH9 C1 cellulase model structure (Figure 35). The graphics program PyMol 
was used to analyse and depict the model for GH9 C1 cellulase.  
 
Figure 35: Model structure of GH9 C1 cellulase generated using SWISS-MODEL. A) GH9 C1 cellulase model 
structure presented as a ribbon diagram using PyMol. Using the rainbow colouring scheme, results in a 
blue N-terminus and a red C-terminus, with intermediate colours cyan, green, yellow and orange in 
between. B) The model of GH9 C1 cellulase (blue) superimposed in the crystal structure of CbhA (cyan) 
(PDB Code: 1UT9). 
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3.3.1. Overall Model Description  
The model structure of the 63 kDa GH9 C1 cellulase reveals the latter to consist of two 
interconnected domains: A smaller N-terminal Ig-like domain spanning residues 1-126 (blue in 
Figure 35A) followed by a much larger catalytic domain (residues 127-524, cyan to red). This 
domain arrangement is typical of the subgroup C of GH9 cellulases (Schubot et al., 2004) and the 
overall fold of the structure is similar to those of previously described family 9 cellulases 
(Chauvaux et al., 1995; Pereira et al., 2009; Schubot et al., 2004). The N-terminal Ig-like domain 
consists of six antiparallel β-strands forming a two layered β-sandwich structurally linked to the 
catalytic domain. The function of the Ig-like domain is unclear though its deletion or extensive 
mutation progressively inactivates (Burstein et al., 2009; Kataeva et al., 2004) and limits the range 
of substrates of the catalytic module. This is similarly true for carbohydrate binding domains of 
related enzymes (Ravachol et al., 2014).  
 
 
Figure 36: The domain structure of GH9 C1 cellulase. Left: Ig-like domain of GH9 C1 
cellulase showing the six β-strand sandwich structure. Right: Catalytic domain showing 
the inner (blue) and outer (green) α-helices. 
 
 
 
 
94 
 
The fold of the GH9 C1 cellulase catalytic domain is similar to those of other GH9 family enzymes. 
The structure consists of twelve α-helices and two antiparallel β-strands. The twelve α-helices 
form a typical (α/α)6-barrel (Schubot et al., 2004; Pereira et al., 2009).  
3.3.2. Metal Ion Binding  
All GH9 cellulases bind metal ions (Chauvaux et al., 1995). The metal-ion binding sites are limited 
to the catalytic domain and never occur in the Ig-like domain. Metal ion binding presumably 
enhances the cellulase thermal stability via intra-domain interactions (Juy et al., 1992; Chauvaux 
et al., 1995) and to stabilize the active conformation.  
The endoglucanase CelD of Clostridium thermocellum binds three Ca2+ and one Zn2+ (Chitarra et 
al., 1995); the endoglunase Cel9A of Alicyclobacillus acidocaldarius binds two Ca2+ and one Zn2+ 
(Pereira et al 2009), while the cellobiohydrolase CbhA of Clostridium thermocellum binds two 
Ca2+ (Schubot et al, 2004). Ca2+-coordinating residues of binding sites 1 and 2 (Figure 37) are 
conserved in GH9 cellulases.  Ca2+-binding site 3, involved in stabilizing the active site (Figure 37), 
is not conserved in CbhA (Schubot et al., 2004). 
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Figure 37: Superimposed structures of GH9 cellulases showing metal ion binding sites. Position 1, 2 and 3 
are Ca2+ binding site (orange spheres). The light orange sphere indicates the Zn2+ binding site conserved 
in some GH9 cellulases. Blue: GH9 C1 cellulase, magenta: endoglunase Cel9A of Alicyclobacillus 
acidocaldarius (3EZ8_Cel9A); grey: endoglucanase CelD of Clostridium thermocellum (1CLC_CelD); yellow: 
cellobiohydrolase CbhA of Clostridium thermocellum with substrate bound (1RQ5_CbhA); cyan: 
Cellobiohydrolase CbhA from Clostridium thermocellum without substrate (1UT9_CbhA).  
 
3.3.2.1. Zn2+-Binding Sites 
To investigate Zn2+ binding by GH9 C1 cellulase, the crystal structures of CelA (PDB code: 3EZ8) 
and Endoglucanase D (PDB code: 1CLC) known to bind Zn2+ were superimposed on the modelled 
structure of GH9 C1 cellulase. The results showed that the amino acids involved in metal binding 
are conserved in the two crystal structures: 2 histidines and 2 cysteines each (magenta and light 
blue in Figure 38). These residues are replaced by tyrosine, histidine, isoleucine and cysteine in 
GH9 C1 cellulase indicating that the latter does not bind Zn2+ (blue in Figure 38). 
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Figure 38: Lack of Zn2+ binding in GH9 C1 cellulase. Superposition of Zn2+ coordinating residues of 
endoglunase Cel9A of Alicyclobacillus acidocaldarius (3EZ8_Cel9A, magenta) and endoglucanase CelD of 
Clostridium thermocellum (1CLC, light blue) with GH9 C1 cellulase (blue). The superimposition shows that 
the residues for Zn2+ coordination are conserved in 3EZ8_Cel9A and 1CLC but not in GH9 C1 cellulase.  
 
3.3.2.2. Ca2+-Binding Sites 
Calcium ions are generally considered hard metal ions. As a result they prefer similarly hard 
oxygen ligands most often from negatively charged glutamate and aspartate side-chains or 
alternatively from serine and threonine side chains and/or main-chain carbonyl atoms. The 
coordination sphere of Ca2+ is classically octahedral with Ca2+-O distances around 2.4 to 2.5 Å. 
Within proteins this coordination sphere is frequently distorted. The cytoplasmic concentration 
of Ca2+ is maintained at very low levels by dedicated Ca2+ pumps. Cytoplasmic proteins therefore 
generally do not bin Ca2+ unless involved in Ca2+-detection and -response. Extracellular Ca2+-
concentrations, by contrast, are much higher and many proteins in this environment use Ca2+-
sites for structural stabilization.  The catalytic domains of GH9 cellulases share up to three Ca2+ 
binding sites with sites 1 and 2 more highly conserved than site 3. 
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Site 1 is near the enzyme active site indicating a stabilizing role for the catalytic domain. In Cel9A 
four residues are involved in coordinating Ca2+.  These are two aspartate residues, one alanine 
and one glutamate. In 1CLC the residues involved are two aspartate, one threonine and one 
serine residues. Analysis of Ca2+ binding site 1 shows that the above are replaced by two 
aspartate, one threonine and one serine residue implying that this site is indeed conserved in 
GH9 C1 cellulase (Figure 39A). The residues aspartate and glutamate coordinates Ca2+ through 
their side chain carbonyl oxygen whereas serine and threonine coordinate through the hydroxyl 
groups. Alanine, however, coordinates Ca2+ through its main chain carbonyl oxygen.  
 
Figure 39: Ca2+ binding sites 1 (B) and 2 (A) in GH9 C1 cellulase. Ca2+-coordinating residues of 3EZ8_Cel9A 
(magenta), 1CLC (light blue) and GH9 C1 cellulase (blue). The superposition shows that Ca2+-binding 
residues of site 2 (A) are conserved, while those of site 2 (B) are not. 
Comparing the possible Ca2+-binding site 2 of GH9 C1 cellulase to equivalent sites in Cel9A and 
1CLC shows aspartate, isoleucine, glutamate and serine are involved in Ca2+-binding in Cel9A, and 
aspartate, valine, histidine and serine in 1CLC. These residues are replaced by valine, proline, 
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glutamate and tryptophan in GH9 C1 cellulase (Figure 39B). These residues do not allow for Ca2+-
binding, implying site 1 not to be conserved in GH9 C1 cellulase.  
To analyse Ca2+-binding site 3 in GH9 C1 cellulase, the site was compared to that of CelD (1CLC). 
Ca2+-coordination here is distorted octahedral with a water molecule at one vertex and protein 
groups providing the five remaining ligands (Chauvaux et al., 2004). The protein ligands include 
two main chain carbonyls as well as one asparagine and two aspartic acid residue side chains. 
These residues are conserved in GH9 C1, indicating site 3 is conserved in GH9 C1 cellulase (Figure 
40). 
  
3.3.3. The Active Site Architecture  
The active site of GH9 C1 cellulase is located between the loops at the N-terminus of the catalytic 
module and near the second calcium ion binding site. The active site is located in an open cleft 
which binds four to six glucose units of cellulose. Figure 41 shows a surface representation of 
GH9 C1 cellulase with a substrate molecule from the crystal structure 1RQ5 modelled into the 
active site.  
Figure 40: Binding of Ca2+ by GH9 C1 cellulase at position 3. 
Conserved residues between GH9 C1 cellulase (Blue) and 1CLC 
(Light blue) at the Ca2+ binding site of 1CLC. The main calcium ion 
coordinating residues are conserved in GH9 C1 cellulase, 
indicating that this site potentially binds calcium ions.  
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Figure 41: Surface view of GH9 C1 cellulase showing active site cleft. A) Surface view of GH9 C1 cellulase 
model structure (Blue) with a substrate molecule (Green) modelled into its active site. B) Surface view of 
GH9 C1 cellulase (Blue) superimposed on 1RQ5 (Magenta) and showing the active site containing a 
substrate molecule (Green). C): Cartoon image of the active site of B showing the secondary structure 
elements around the active site cleft. 
  
A detailed analysis of the active site residues suggest that the conserved amino acids Phe266, 
Tyr344, Leu396, Trp447 and His506 mediate sugar binding through stacking van der Waals 
interactions with the glucose rings (Figure 42) as frequently observed for protein-sugar binding 
(Vyas, 1991). The interactions are flexible to allow sliding of the substrate across the active site. 
In addition, intricate hydrogen bonding network between cellulose and amino acid side chains 
are observed including Asp188, Asp191 and Arg508. 
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Figure 42: Conserved residues at the active site of GH9 C1 cellulase. The residues are involved in hydrogen 
bonding and base stacking with the substrate molecule. Green: Substrate molecule; Blue: Residues of the 
GH9 C1 cellulase model structure; Magenta: Active site residues of 1RQ5.  
 
3.3.4. Mechanism of Action 
Cellulases catalyse the hydrolysis of β-1,4-glucosidic bonds through general acid catalysis 
(Sinnott, 1990) with two acidic residues (glutamate or aspartate) being essential (Davies & 
Henrissat, 1995). Hydrolysis further retains or inverts the configuration of the substrate. To retain 
the configuration, one of the two catalytic residues nucleophilically attacks the substrate forming 
a covalent glycosyl-enzyme intermediate. The second catalytic residue, a general acid/base, then 
first protonates the leaving group following the formation of the covalent intermediate and then 
activates the incoming nucleophile, often a water molecule. The glycosyl-enzyme intermediate is 
both formed and hydrolysed via an oxocarbenium ion-like transition state. 
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In the inversion mechanism, one of the catalytic residues, a proton donor, protonates the 
glycosidic oxygen and promotes the leaving group to depart. The other catalytic residue acts as 
a general base, activating nucleophilic water by deprotonating it. The result is an oxocarbenium-
ion-like transition state with electron density distributed over eight atoms resulting in three 
bonds being broken and formed in a concerted fashion (Withers, 2001). 
GH9 C1 cellulase is an inverting enzyme. Asp190 and Asp193 constitute the conserved catalytic 
residues. Asp193 deprotonates a water molecule, which then nucleophilically attacks the 
anomeric carbon of the targeted glucose subunit. Another conserved residue Asn609 stabilizes 
the transition state during catalysis. Asp190 presumably serves as proton donor for the oxygen 
(O-4) in the glycosidic bond to be broken, while Asp193 serves as the catalytic base activating the 
nucleophilic water to attack the anomeric carbon (C-1). This results in the inversion of the original 
stereochemistry of the product.  
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4. Conclusion and Outlook 
This study was aimed at structurally analysing the enzyme GH9 C1 cellulase obtained from a hot 
compost metagenomic library. The protein was readily produced in E. coli and purified using 
chromatographic techniques. The homogenously pure protein was concentrated and used for 
crystallization. Crystallization conditions for GH9 C1 cellulase were established and refined to 
improve crystal size and morphology. The crystals, however, diffracted X-rays to a mere 4 Å 
resolution. Recorded diffraction data could not be used to solve the crystal structure of GH9 C1 
cellulase. Instead the structure of GH9 C1 cellulase was modelled on the experimental structure 
of CbhA (PDB ID: 1UT9) from Clostridium thermocellum by homology modelling and analysed 
using the graphics program PyMol. Analysis revealed a similar fold to other GH9 family members 
included two linked domains. Two Ca2+-binding sites were found to be conserved in GH9 C1 
cellulase and the amino acids for substrate binding and catalysis were identified.  
Owing to time constraints, further optimisation of crystallization conditions for high resolution 
diffraction quality crystals could not be pursued. Future studies on this protein will involve the 
further improvement of the crystallization conditions for better diffraction quality crystals to 
allow the structure of GH9 C1 cellulase to be determined and refined experimentally.  
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